JPH0515704B2 - - Google Patents
Info
- Publication number
- JPH0515704B2 JPH0515704B2 JP62092129A JP9212987A JPH0515704B2 JP H0515704 B2 JPH0515704 B2 JP H0515704B2 JP 62092129 A JP62092129 A JP 62092129A JP 9212987 A JP9212987 A JP 9212987A JP H0515704 B2 JPH0515704 B2 JP H0515704B2
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- lower alkylene
- methyl
- formula
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims description 102
- 125000002947 alkylene group Chemical group 0.000 claims description 65
- 125000000217 alkyl group Chemical group 0.000 claims description 40
- -1 3-indolyl Chemical group 0.000 claims description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims description 27
- 239000001257 hydrogen Substances 0.000 claims description 26
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 24
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 20
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 19
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 15
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 125000001424 substituent group Chemical group 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 4
- MPFLRYZEEAQMLQ-UHFFFAOYSA-N dinicotinic acid Chemical compound OC(=O)C1=CN=CC(C(O)=O)=C1 MPFLRYZEEAQMLQ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical group 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 150000003462 sulfoxides Chemical class 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 125000001041 indolyl group Chemical group 0.000 claims 5
- UYSUUCWAEKLKAN-UHFFFAOYSA-N 5-(3-nitrophenoxy)carbonylpyridine-3-carboxylic acid Chemical compound OC(=O)C1=CN=CC(C(=O)OC=2C=C(C=CC=2)[N+]([O-])=O)=C1 UYSUUCWAEKLKAN-UHFFFAOYSA-N 0.000 claims 3
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- GJAWHXHKYYXBSV-UHFFFAOYSA-L quinolinate(2-) Chemical compound [O-]C(=O)C1=CC=CN=C1C([O-])=O GJAWHXHKYYXBSV-UHFFFAOYSA-L 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- 239000000543 intermediate Substances 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 239000000047 product Substances 0.000 description 27
- 239000000243 solution Substances 0.000 description 24
- 239000003921 oil Substances 0.000 description 23
- 238000000034 method Methods 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000000203 mixture Substances 0.000 description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000002844 melting Methods 0.000 description 16
- 230000008018 melting Effects 0.000 description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000007788 liquid Substances 0.000 description 13
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000377 silicon dioxide Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 8
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000003818 flash chromatography Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000012266 salt solution Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 238000000023 Kugelrohr distillation Methods 0.000 description 5
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000007429 general method Methods 0.000 description 5
- 208000028867 ischemia Diseases 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000001308 synthesis method Methods 0.000 description 5
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 4
- 239000005695 Ammonium acetate Substances 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 235000019257 ammonium acetate Nutrition 0.000 description 4
- 229940043376 ammonium acetate Drugs 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 125000003710 aryl alkyl group Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 239000012263 liquid product Substances 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000009518 sodium iodide Nutrition 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 230000003595 spectral effect Effects 0.000 description 4
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000002253 anti-ischaemic effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical compound CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- NIKAJNOLEDWFSF-UHFFFAOYSA-N 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid;hydrochloride Chemical compound Cl.OC(=O)C1=C(C)NC(C)=C(C(O)=O)C1C1=CC=CC([N+]([O-])=O)=C1 NIKAJNOLEDWFSF-UHFFFAOYSA-N 0.000 description 2
- LAMUXTNQCICZQX-UHFFFAOYSA-N 3-chloropropan-1-ol Chemical compound OCCCCl LAMUXTNQCICZQX-UHFFFAOYSA-N 0.000 description 2
- PRMNESORVLFXBR-UHFFFAOYSA-N 3-chloropropyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OCCCCl PRMNESORVLFXBR-UHFFFAOYSA-N 0.000 description 2
- MHSWCKAYODIGCG-UHFFFAOYSA-N 3-methyl-1,3-oxazinan-2-one Chemical compound CN1CCCOC1=O MHSWCKAYODIGCG-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- QAWTYRYXDYHQNU-UHFFFAOYSA-N diazathiane Chemical compound NSN QAWTYRYXDYHQNU-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- LYUBYLJQOZIBQB-UHFFFAOYSA-N methyl 2-[(3-nitrophenyl)methylidene]-3-oxobutanoate Chemical compound COC(=O)C(C(C)=O)=CC1=CC=CC([N+]([O-])=O)=C1 LYUBYLJQOZIBQB-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000003375 sulfoxide group Chemical group 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- JVTRZJXFAOQMRA-UHFFFAOYSA-N 1,3-oxazin-2-one Chemical compound O=C1N=CC=CO1 JVTRZJXFAOQMRA-UHFFFAOYSA-N 0.000 description 1
- DNRDXYPXBYGQGQ-UHFFFAOYSA-N 1-(3-chloropropyl)-2h-pyridine Chemical compound ClCCCN1CC=CC=C1 DNRDXYPXBYGQGQ-UHFFFAOYSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JONTXEXBTWSUKE-UHFFFAOYSA-N 2-(2-aminoethylsulfanyl)ethanamine Chemical compound NCCSCCN JONTXEXBTWSUKE-UHFFFAOYSA-N 0.000 description 1
- UEFBOQYLXLEJSM-UHFFFAOYSA-N 2-bromoethylsulfanylbenzene Chemical compound BrCCSC1=CC=CC=C1 UEFBOQYLXLEJSM-UHFFFAOYSA-N 0.000 description 1
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 1
- KDDDCSPWRLHCLZ-UHFFFAOYSA-N 3-(2-phenylsulfanylethyl)-1,3-oxazolidin-2-one Chemical compound O=C1OCCN1CCSC1=CC=CC=C1 KDDDCSPWRLHCLZ-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- DBVTYDLZMXNRIN-UHFFFAOYSA-N 3-benzyl-1,3-oxazolidin-2-one Chemical compound O=C1OCCN1CC1=CC=CC=C1 DBVTYDLZMXNRIN-UHFFFAOYSA-N 0.000 description 1
- ZETIVVHRRQLWFW-UHFFFAOYSA-N 3-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC(C=O)=C1 ZETIVVHRRQLWFW-UHFFFAOYSA-N 0.000 description 1
- JLAKCHGEEBPDQI-UHFFFAOYSA-N 4-(4-fluorobenzyl)piperidine Chemical compound C1=CC(F)=CC=C1CC1CCNCC1 JLAKCHGEEBPDQI-UHFFFAOYSA-N 0.000 description 1
- FBXGQDUVJBKEAJ-UHFFFAOYSA-N 4h-oxazin-3-one Chemical compound O=C1CC=CON1 FBXGQDUVJBKEAJ-UHFFFAOYSA-N 0.000 description 1
- UIXDJIVSGNZMTF-UHFFFAOYSA-N 5-[4-(butylamino)butoxycarbonyl]-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid Chemical compound CCCCNCCCCOC(=O)C1=C(C)NC(C)=C(C(O)=O)C1C1=CC=CC([N+]([O-])=O)=C1 UIXDJIVSGNZMTF-UHFFFAOYSA-N 0.000 description 1
- LDZKEVJFPLPBGM-UHFFFAOYSA-N 5-methoxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.COC(=O)C1=C(C)NC(C)=C(C(O)=O)C1C1=CC=CC([N+]([O-])=O)=C1 LDZKEVJFPLPBGM-UHFFFAOYSA-N 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108090000312 Calcium Channels Proteins 0.000 description 1
- 102000003922 Calcium Channels Human genes 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- XUZYCEHLXRTJMH-UHFFFAOYSA-N N[N]N Chemical group N[N]N XUZYCEHLXRTJMH-UHFFFAOYSA-N 0.000 description 1
- YGLGPZDDSCQFPD-UHFFFAOYSA-N O.Cl.CC=1NC(=C(C(C1C(=O)O)C1=CC(=CC=C1)[N+](=O)[O-])C(=O)O)C Chemical compound O.Cl.CC=1NC(=C(C(C1C(=O)O)C1=CC(=CC=C1)[N+](=O)[O-])C(=O)O)C YGLGPZDDSCQFPD-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- MMCPOSDMTGQNKG-UHFFFAOYSA-N anilinium chloride Chemical compound Cl.NC1=CC=CC=C1 MMCPOSDMTGQNKG-UHFFFAOYSA-N 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 230000002213 calciumantagonistic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- PUSKHXMZPOMNTQ-UHFFFAOYSA-N ethyl 2,1,3-benzoselenadiazole-5-carboxylate Chemical compound CCOC(=O)C1=CC=C2N=[Se]=NC2=C1 PUSKHXMZPOMNTQ-UHFFFAOYSA-N 0.000 description 1
- YOPMSDPIOQUWFE-UHFFFAOYSA-N ethyl 2-[(3-nitrophenyl)methylidene]-3-oxobutanoate Chemical compound CCOC(=O)C(C(C)=O)=CC1=CC=CC([N+]([O-])=O)=C1 YOPMSDPIOQUWFE-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- CCESALWCJQJVQQ-UHFFFAOYSA-N n-methyl-3-phenylsulfanylpropan-1-amine;hydrochloride Chemical compound Cl.CNCCCSC1=CC=CC=C1 CCESALWCJQJVQQ-UHFFFAOYSA-N 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 229940032330 sulfuric acid Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
æ¬çºæã¯ã¢ã«ãã¬ã³ã¢ããã¢ã«ãã¬ã³ ããã
åååºéšåã«ïŒâã«ã«ããã·ã¬ãŒãåºãçµåããŠ
ããïŒïŒïŒâãžãããããªãžã³ç³»ã®è€çŽ ç°ç¶ççŽ
ååç©ã«é¢ããããããã®ååç©ã¯çäœã«æçšãª
æ§è³ªããã€ãŠããã åŸæ¥ïŒâã¢ãªãŒã«âïŒïŒïŒâãžãããããªãžã³
é¡ååç©ãå«ãååç©ã¯æè¿10幎éã«éçºãããŠ
ããããããã¯ã«ã«ã·ãŠã æ®ææ§ããã¡å¿èè¡ç®¡
ç æ²»çã«æçšã§ããããã®ã«ã«ã·ãŠã æå¶å¹æã¯
è¡ç®¡æ¡åŒµã仲ä»ãããšæããåçŸç ãé«è¡å§çã«
ãã®ååç©ãæçšãšããããã®ã·ãªãŒãºã®æšæºç
ååç©ã¯äºããšãžãã³ïŒåŒïŒïŒïŒ ã§ãããååŠçã«ïŒâïŒ2â²âãããããšãã«ïŒâ
ïŒïŒïŒâãžã¡ãã«âïŒïŒïŒâãžã«ã«ãã¡ããã·â
ïŒïŒïŒâãžãããããªãžã³ã§ãããäºããšãžãã³
ãšé¢é£ããïŒâã¢ãªãŒã«âïŒïŒïŒâãžãããããª
ãžã³ã¯1969幎12æ23æ¥å ¬åã®ç±³åœç¹èš±ç¬¬3485847
å·ã®äž»é¡ã§ããã以åŸä»ã®çœ®æåºãååŠççµååº
ã®å€æ§æ§ã«ãããžãããããªãžã³ã®çš®ã ã®ç°äœçœ®
ã«çµèŸŒãã ïŒïŒïŒâãžãããããªãžã³ã«ã€ããŠå€
ãã®ç¹èš±ãå ¬åãããŠããããã®çš®ã®ååç©ã«é¢
ããå€æ°é¢é£ç¹èš±ã®å€ãã¯ãžãããããªãžã³æ žã®
ã«ã«ããã·ã¬ãŒãåºã®ïŒåã¯äž¡æ¹ã«æ¯èŒçå ããª
æ§é å€åã«ããã¡ãã€ãŠããã®ã§ããã ç±³åœç¹èš±ç¬¬3985785å·ã¯æçšãªè¡ç®¡æ¡åŒµå€ãäº
ã«ã«ãžãã³(2)ïŒ ãšãã®é¢é£ååç©ãé瀺ããŠããã äºã«ã«ãžãã³ã«é¢ä¿ã®ååç©ã®ä»ã®ã·ãªãŒãºã¯
äžè¬åŒ(3)ïŒ ã§è¡šãããããäžåŒäžR2ãR4ãR5ããã³R6ã¯å
ã«å€ãã®ãžãããããªãžã³æç®ã«å埩説æãããŠ
ããå€ãã®çœ®æåºã®ã©ãã§ãããããããïŒïŒïŒ
âãžãããããªãžã³ç°ã®ïŒâäœçœ®ã«çµåããŠãã
眮æåºæ§é 説æã«ç¹å¥ã®æ³šæãåããããŠããã
ïŒâäœçœ®æ§é éšåã¯ã¢ã«ãã¬ã³éã«ããã«ã«ãã
ã·ã¬ãŒãåºã«çµåããŠãã第ïŒçŽåã¯ç¬¬ïŒçŽã¢ã
ãå®èœåºããæããççŽ ååïŒä¹è³ïŒã®ã¢ã«ãã¬
ã³åºã¯çŽéã§ãåå²éã§ããããããå Žåã¢ãªãŒ
ã«åã¯ãã¿ãªãŒã«åºãã¢ã«ãã¬ã³éã«ã€ããŠã
ããïŒã¢ããçªçŽ 眮æåºã«å¯ŸãR7ã¯æ°ŽçŽ åã¯ã¢
ã«ãã«ã§ããR8ã¯ã¢ã«ãã«ãã¢ã©ã«ãã«åã¯ã¢
ãªãŒã«ã§ãããã次ã®æç®ã¯ïŒ£âïŒæ§é éšååŒ(4) ããã€äºã«ã«ãžãã³åååç©ã«é¢ããæè¡ã代衚
ããŠããã ã¢ã©ããã®ç±³åœç¹èš±ç¬¬4423052å·ã¯ïœãïŒã§ã
ãïœãïŒåã¯ïŒã§ãããR7ãšR8ãã¢ã«ãã«åã¯
ã¢ãªãŒã«ã¢ã«ãã«ã§ãããR9ãæ°ŽçŽ ã§ãããã€
R10ãã¢ãªãŒã«ã§ããååç©ãé瀺ããŠããã Chem.AbstractsïŒ98ã107166iïŒ1983ïŒã«ïœã
ïŒä¹è³ïŒã§ãããïœãïŒåã¯ïŒã§ãããR7ãšR8
ãã¢ã«ãã«åã¯ã¢ã©ã«ãã«ã§ãããR9ãæ°ŽçŽ ã§
ããããã€R10ãã¢ãªãŒã«ã§ããåæ§ã®ååç©ã
é瀺ãããã ãšãŒãããç¹èš±åºé¡128010å·ã«ïœãšïœãïŒä¹è³
ïŒã§ãããR7ãšR9ãã¢ã«ãã«ã§ãããR8ã眮æ
ã¢ã©ã«ãã«ã§ãããã€R10ãæ°ŽçŽ åã¯ã¢ã«ãã«ã§
ããååç©ãé瀺ãããŠããã æ¥æ¬ã®ç¹éJS8157785AïŒAbstracts No.83â
798692ïŒ43ïŒã«ïœãïŒã§ããïœãïŒåã¯ïŒã§ãã
R7ãšR8ãã¢ã«ãã«ã§ãããR9ãæ°ŽçŽ ã§ãããã€
R10ãè€çŽ ç°ç¶åºã§ããååç©ãé瀺ãããã ç¹èš±åºé¡ãäŸãã°å¯å±±ååŠ(æ ª)ã®DE3522â579â
ïŒAbstracts No.86â008339ïŒ02ïŒã¯R7ã
åååºéšåã«ïŒâã«ã«ããã·ã¬ãŒãåºãçµåããŠ
ããïŒïŒïŒâãžãããããªãžã³ç³»ã®è€çŽ ç°ç¶ççŽ
ååç©ã«é¢ããããããã®ååç©ã¯çäœã«æçšãª
æ§è³ªããã€ãŠããã åŸæ¥ïŒâã¢ãªãŒã«âïŒïŒïŒâãžãããããªãžã³
é¡ååç©ãå«ãååç©ã¯æè¿10幎éã«éçºãããŠ
ããããããã¯ã«ã«ã·ãŠã æ®ææ§ããã¡å¿èè¡ç®¡
ç æ²»çã«æçšã§ããããã®ã«ã«ã·ãŠã æå¶å¹æã¯
è¡ç®¡æ¡åŒµã仲ä»ãããšæããåçŸç ãé«è¡å§çã«
ãã®ååç©ãæçšãšããããã®ã·ãªãŒãºã®æšæºç
ååç©ã¯äºããšãžãã³ïŒåŒïŒïŒïŒ ã§ãããååŠçã«ïŒâïŒ2â²âãããããšãã«ïŒâ
ïŒïŒïŒâãžã¡ãã«âïŒïŒïŒâãžã«ã«ãã¡ããã·â
ïŒïŒïŒâãžãããããªãžã³ã§ãããäºããšãžãã³
ãšé¢é£ããïŒâã¢ãªãŒã«âïŒïŒïŒâãžãããããª
ãžã³ã¯1969幎12æ23æ¥å ¬åã®ç±³åœç¹èš±ç¬¬3485847
å·ã®äž»é¡ã§ããã以åŸä»ã®çœ®æåºãååŠççµååº
ã®å€æ§æ§ã«ãããžãããããªãžã³ã®çš®ã ã®ç°äœçœ®
ã«çµèŸŒãã ïŒïŒïŒâãžãããããªãžã³ã«ã€ããŠå€
ãã®ç¹èš±ãå ¬åãããŠããããã®çš®ã®ååç©ã«é¢
ããå€æ°é¢é£ç¹èš±ã®å€ãã¯ãžãããããªãžã³æ žã®
ã«ã«ããã·ã¬ãŒãåºã®ïŒåã¯äž¡æ¹ã«æ¯èŒçå ããª
æ§é å€åã«ããã¡ãã€ãŠããã®ã§ããã ç±³åœç¹èš±ç¬¬3985785å·ã¯æçšãªè¡ç®¡æ¡åŒµå€ãäº
ã«ã«ãžãã³(2)ïŒ ãšãã®é¢é£ååç©ãé瀺ããŠããã äºã«ã«ãžãã³ã«é¢ä¿ã®ååç©ã®ä»ã®ã·ãªãŒãºã¯
äžè¬åŒ(3)ïŒ ã§è¡šãããããäžåŒäžR2ãR4ãR5ããã³R6ã¯å
ã«å€ãã®ãžãããããªãžã³æç®ã«å埩説æãããŠ
ããå€ãã®çœ®æåºã®ã©ãã§ãããããããïŒïŒïŒ
âãžãããããªãžã³ç°ã®ïŒâäœçœ®ã«çµåããŠãã
眮æåºæ§é 説æã«ç¹å¥ã®æ³šæãåããããŠããã
ïŒâäœçœ®æ§é éšåã¯ã¢ã«ãã¬ã³éã«ããã«ã«ãã
ã·ã¬ãŒãåºã«çµåããŠãã第ïŒçŽåã¯ç¬¬ïŒçŽã¢ã
ãå®èœåºããæããççŽ ååïŒä¹è³ïŒã®ã¢ã«ãã¬
ã³åºã¯çŽéã§ãåå²éã§ããããããå Žåã¢ãªãŒ
ã«åã¯ãã¿ãªãŒã«åºãã¢ã«ãã¬ã³éã«ã€ããŠã
ããïŒã¢ããçªçŽ 眮æåºã«å¯ŸãR7ã¯æ°ŽçŽ åã¯ã¢
ã«ãã«ã§ããR8ã¯ã¢ã«ãã«ãã¢ã©ã«ãã«åã¯ã¢
ãªãŒã«ã§ãããã次ã®æç®ã¯ïŒ£âïŒæ§é éšååŒ(4) ããã€äºã«ã«ãžãã³åååç©ã«é¢ããæè¡ã代衚
ããŠããã ã¢ã©ããã®ç±³åœç¹èš±ç¬¬4423052å·ã¯ïœãïŒã§ã
ãïœãïŒåã¯ïŒã§ãããR7ãšR8ãã¢ã«ãã«åã¯
ã¢ãªãŒã«ã¢ã«ãã«ã§ãããR9ãæ°ŽçŽ ã§ãããã€
R10ãã¢ãªãŒã«ã§ããååç©ãé瀺ããŠããã Chem.AbstractsïŒ98ã107166iïŒ1983ïŒã«ïœã
ïŒä¹è³ïŒã§ãããïœãïŒåã¯ïŒã§ãããR7ãšR8
ãã¢ã«ãã«åã¯ã¢ã©ã«ãã«ã§ãããR9ãæ°ŽçŽ ã§
ããããã€R10ãã¢ãªãŒã«ã§ããåæ§ã®ååç©ã
é瀺ãããã ãšãŒãããç¹èš±åºé¡128010å·ã«ïœãšïœãïŒä¹è³
ïŒã§ãããR7ãšR9ãã¢ã«ãã«ã§ãããR8ã眮æ
ã¢ã©ã«ãã«ã§ãããã€R10ãæ°ŽçŽ åã¯ã¢ã«ãã«ã§
ããååç©ãé瀺ãããŠããã æ¥æ¬ã®ç¹éJS8157785AïŒAbstracts No.83â
798692ïŒ43ïŒã«ïœãïŒã§ããïœãïŒåã¯ïŒã§ãã
R7ãšR8ãã¢ã«ãã«ã§ãããR9ãæ°ŽçŽ ã§ãããã€
R10ãè€çŽ ç°ç¶åºã§ããååç©ãé瀺ãããã ç¹èš±åºé¡ãäŸãã°å¯å±±ååŠ(æ ª)ã®DE3522â579â
ïŒAbstracts No.86â008339ïŒ02ïŒã¯R7ã
ãåŒãïŒäœãããåã¯ããã¬
ã³ã§ãããã¯ïŒ¯ãåã¯ã¢ã«ãã¬ã³ã§ããã¯
çªçŽ ããã€è€çŽ ç°ã§ããïŒã§ããååç©ãé瀺ã
ãŠããã äžè¬åŒ(5)ïŒ ã§ç€ºãããååç©ã¯æ¬çºæã®ååç©ãšã®é¢é£æ§ã¯
èãããã®çš®ã®ååç©ã¯åŽéã¢ããçªçŽ ååãäž
è¬ã«ïŒâïŒå¡ããã€ç°ã«å ¥ã€ãŠããããšã«ããåº
å¥ããããããå Žåç°ã¯çªçŽ ã®æ§ãªä»ã®ãããå
åããã€ãäŸãã°ããã©ãžã³ç°ã§ããããžããã
ããªãžã³ã«äŒŒãæ§é (5)ããã€ãã®åã®ä»£è¡šçæç®
ã«ã¯æ¬¡ã®ãã®ãããïŒ ãšãŒãããç¹èš±åºé¡88903âïŒåå¯è£œè¬(æ ª)ïŒã
ãšãŒãããç¹èš±åºé¡94159âïŒæŠç°è¬å(æ ª)ïŒããš
ãŒãããç¹èš±åºé¡97821ïŒãã¬ã«SPAïŒã æ¬çºæã®ååç©ã¯ãããååãšçã¢ã«ãã¬ã³é
ã«ãã€ãŠïŒâã«ã«ããã·ã¬ãŒãåŽéã®ã¢ããçªçŽ
ååã«çµåããŠããè¿œå ã¢ãªãŒã«åã¯ãã¿ãªãŒã«
éšåããã€ç¹ã§åœè©²åéã§æçã«åºå¥ããããåŸ
æ¥æè¡ã«ãã€ãŠç€ºåããããæããã«ãããªãã€
ããã®ç¹æ®æ§é ãè¡ç®¡æ¡åŒµå€ãšããŠæçšãªè¬çåŠ
çæ§è³ªããã€ååç©ãç£ãã ã®ã§ãããå®éæ¬å
åç©ã¯ååæ§é ã®åºæ¬ã«ãããŠãŸãççåŠçäœçš
ã«ãããŠãäž¡æ¹ã§åŸæ¥ååç©ãšåºå¥ããããæ¬å
åç©ã¯åŸæ¥ååç©ãšåæ§ã«ã«ã·ãŠã ãã€ã³ãã«é»
害æ§ããã€ããæ¬ååç©ã¯ãŸãèè¡ã®é²æ¢ããã³
è¡å°æ¿åéæå¶ã«æçšãªäœçšããã€ããšãèŠåºã
ãããçµå±æ¬çºæã®ååç©ãäºæž¬åã¯ç€ºåããåŸ
æ¥æç®ã¯å šããªãã€ãã®ã§ããã æ¬çºæã¯åŒïŒ ã§ç€ºãããååç©ããã³ãã®é žä»å å¡©ã«é¢ããã
äžåŒäžR2ãR5ãR6ãR7ãïœãããã³ïŒºã¯æ¬¡ã®
æå³ããã€ãR2ãR5ããã³R6ã¯åç¡é¢ä¿ã«äœçŽ
ïŒC1-4ïŒã¢ã«ãã«ãããããã·âäœçŽã¢ã«ãã¬ã³ã
äœçŽã¢ã«ã³ãã·âäœçŽã¢ã«ãã¬ã³ãäœçŽã¢ã«ãã«
âã¢ããäœçŽã¢ã«ãã¬ã³ãåã¯äœçŽãžã¢ã«ãã«ã¢
ããâäœçŽã¢ã«ãã¬ã³ããããã°ããåçš®åã¯ç°
çš®ã§ããããâäœçŽâãšã¯ççŽ ååïŒä¹è³ïŒãåº
ãæãæå³ã§ããã¢ã«ãã«ãã¢ã«ã³ãã·åã¯ã¢ã«
ãã¬ã³çã«çšãããäŸãã°äœçŽã¢ã«ã³ãã·âäœçŽ
ã¢ã«ãã¬ã³ãšã¯C1âC4ã¢ã«ãã¬ã³éããã³é žçŽ
ååã§çµåãããC1âC4ã¢ã«ãã«åºããããå
æ§ã«ã¢ã«ãã«ã¢ããã¢ã«ãã«ãšãžã¢ã«ãã«ã¢ãã
ã¢ã«ãã«ãšã¯ç¬¬ïŒçŽïŒâNHâïŒåã¯ç¬¬ïŒçŽïŒïŒ®
â¡ïŒã¢ããåºã«ããçµåãããäœçŽã¢ã«ãã«åºãš
äœçŽã¢ã«ãã¬ã³éããããR7ã¯æ°ŽçŽ ãäœçŽã¢ã«
ãã«ãããšãã«âäœçŽã¢ã«ãã¬ã³ãåã¯ããšãã«
ããªâäœçŽã¢ã«ãã¬ã³ããããã°ãããã®ã§ã
ããïœã¯ïŒåã¯ïŒã®æŽæ°ããããããã¯ååŠçµ
åãé žçŽ åã¯ãããååãã¹ã«ããªãã·ãåº
çªçŽ ããã€è€çŽ ç°ã§ããïŒã§ããååç©ãé瀺ã
ãŠããã äžè¬åŒ(5)ïŒ ã§ç€ºãããååç©ã¯æ¬çºæã®ååç©ãšã®é¢é£æ§ã¯
èãããã®çš®ã®ååç©ã¯åŽéã¢ããçªçŽ ååãäž
è¬ã«ïŒâïŒå¡ããã€ç°ã«å ¥ã€ãŠããããšã«ããåº
å¥ããããããå Žåç°ã¯çªçŽ ã®æ§ãªä»ã®ãããå
åããã€ãäŸãã°ããã©ãžã³ç°ã§ããããžããã
ããªãžã³ã«äŒŒãæ§é (5)ããã€ãã®åã®ä»£è¡šçæç®
ã«ã¯æ¬¡ã®ãã®ãããïŒ ãšãŒãããç¹èš±åºé¡88903âïŒåå¯è£œè¬(æ ª)ïŒã
ãšãŒãããç¹èš±åºé¡94159âïŒæŠç°è¬å(æ ª)ïŒããš
ãŒãããç¹èš±åºé¡97821ïŒãã¬ã«SPAïŒã æ¬çºæã®ååç©ã¯ãããååãšçã¢ã«ãã¬ã³é
ã«ãã€ãŠïŒâã«ã«ããã·ã¬ãŒãåŽéã®ã¢ããçªçŽ
ååã«çµåããŠããè¿œå ã¢ãªãŒã«åã¯ãã¿ãªãŒã«
éšåããã€ç¹ã§åœè©²åéã§æçã«åºå¥ããããåŸ
æ¥æè¡ã«ãã€ãŠç€ºåããããæããã«ãããªãã€
ããã®ç¹æ®æ§é ãè¡ç®¡æ¡åŒµå€ãšããŠæçšãªè¬çåŠ
çæ§è³ªããã€ååç©ãç£ãã ã®ã§ãããå®éæ¬å
åç©ã¯ååæ§é ã®åºæ¬ã«ãããŠãŸãççåŠçäœçš
ã«ãããŠãäž¡æ¹ã§åŸæ¥ååç©ãšåºå¥ããããæ¬å
åç©ã¯åŸæ¥ååç©ãšåæ§ã«ã«ã·ãŠã ãã€ã³ãã«é»
害æ§ããã€ããæ¬ååç©ã¯ãŸãèè¡ã®é²æ¢ããã³
è¡å°æ¿åéæå¶ã«æçšãªäœçšããã€ããšãèŠåºã
ãããçµå±æ¬çºæã®ååç©ãäºæž¬åã¯ç€ºåããåŸ
æ¥æç®ã¯å šããªãã€ãã®ã§ããã æ¬çºæã¯åŒïŒ ã§ç€ºãããååç©ããã³ãã®é žä»å å¡©ã«é¢ããã
äžåŒäžR2ãR5ãR6ãR7ãïœãããã³ïŒºã¯æ¬¡ã®
æå³ããã€ãR2ãR5ããã³R6ã¯åç¡é¢ä¿ã«äœçŽ
ïŒC1-4ïŒã¢ã«ãã«ãããããã·âäœçŽã¢ã«ãã¬ã³ã
äœçŽã¢ã«ã³ãã·âäœçŽã¢ã«ãã¬ã³ãäœçŽã¢ã«ãã«
âã¢ããäœçŽã¢ã«ãã¬ã³ãåã¯äœçŽãžã¢ã«ãã«ã¢
ããâäœçŽã¢ã«ãã¬ã³ããããã°ããåçš®åã¯ç°
çš®ã§ããããâäœçŽâãšã¯ççŽ ååïŒä¹è³ïŒãåº
ãæãæå³ã§ããã¢ã«ãã«ãã¢ã«ã³ãã·åã¯ã¢ã«
ãã¬ã³çã«çšãããäŸãã°äœçŽã¢ã«ã³ãã·âäœçŽ
ã¢ã«ãã¬ã³ãšã¯C1âC4ã¢ã«ãã¬ã³éããã³é žçŽ
ååã§çµåãããC1âC4ã¢ã«ãã«åºããããå
æ§ã«ã¢ã«ãã«ã¢ããã¢ã«ãã«ãšãžã¢ã«ãã«ã¢ãã
ã¢ã«ãã«ãšã¯ç¬¬ïŒçŽïŒâNHâïŒåã¯ç¬¬ïŒçŽïŒïŒ®
â¡ïŒã¢ããåºã«ããçµåãããäœçŽã¢ã«ãã«åºãš
äœçŽã¢ã«ãã¬ã³éããããR7ã¯æ°ŽçŽ ãäœçŽã¢ã«
ãã«ãããšãã«âäœçŽã¢ã«ãã¬ã³ãåã¯ããšãã«
ããªâäœçŽã¢ã«ãã¬ã³ããããã°ãããã®ã§ã
ããïœã¯ïŒåã¯ïŒã®æŽæ°ããããããã¯ååŠçµ
åãé žçŽ åã¯ãããååãã¹ã«ããªãã·ãåº
ãåŒãåã¯âNR9âïŒäœãR9ã¯æ°ŽçŽ ãäœçŽã¢
ã«ãã«ãããšãã«åã¯ããšãã«âäœçŽã¢ã«ãã¬ã³
ã§ãããïŒã§ãããããååŠçµåã§ãããšãã«
éãã¯ïŒâã€ã³ããªã«åºã§ãããšããæ¡ä»¶ãã
ããã¯ç¡é¢ä¿ã«æ°ŽçŽ ãäœçŽã¢ã«ãã«åã¯äœçŽã¢
ã«ã³ãã·ãããšãã«âäœçŽã¢ã«ãã¬ã³åã¯ïŒâã€
ã³ããŒã«ããããã°ããïŒä¹è³ïŒã®çœ®æåºã§çœ®æ
ãããããšãã«ããæã矀ããããã°ããã æ¬çºæã®å¥œãŸããååç©ã¯åŒã«ãããŠR2ã
R5ãR6ããã³R7ãäœçŽã¢ã«ãã«ã§ããããã
ããåååã¯NR9ã§ããã€ïŒºãããšãã«ã§ãã
æ§ãªæ§é åŒããã€ãæã奜ãŸããååç©ã¯ïœãïŒ
ã§ããR7ãã¡ãã«ããããã€ïŒžããããååå
ã¯NR9ã§ããæ§ãªãã®ã§ããã æ¬çºæã®ååç©ã¯å åŠç°æ§äœãšããŠååšããã
ããã®ç°æ§äœã®ã©ã»ãæ··åç©äžŠã³ã«åã ã®å åŠç°
æ§äœèªèº«ãæ¬çºæã®ç¯å²å ã§ãããã©ã»ãæ··åç©
ã¯å åŠç掻æ§é žã§çæããããžãšã¹ããªãªã¡ã«å¡©
ãåé¢ããåŸå åŠç掻æ§å¡©åºã«è»¢åãæ»ãæ§ãªç¥
ãããæ¹æ³ã§åã ã®ç°æ§äœã«åé¢ã§ããã äžèšã®ãšããæ¬çºæã¯ãŸããã®åºæ¬ååç©ã®è£œ
è¬äžèš±å®¹ãããç¡æ¯å¡©ã«ãé¢ããããã®å¡©ã«ã¯æ
æ©ãšç¡æ©é žãäŸãã°å¡©é žãèåæ°ŽçŽ é žããªã³é žã
ç¡«é žãã¡ã¿ã³ã¹ã«ããªã³é žãé ¢é žãé ç³é žãä¹³
é žããã¯ãé žããããé žããã¬ã€ã³é žããœã«ãã³
é žãã¢ã³ãããé žããµãªãã«é žããã¿ã«é žããšã³
ãããã¯é žããªãã³ãé žçããèªå°ãããå¡©ãã
ããããããã«éå®ãããã®ã§ã¯ãªãã æ¬çºæã®ååç©ã¯é©åœãªåºçºç©è³ªã«å¿çšããã
ãã³ããŠïŒHantschïŒåæåå¿å€æ³ãçšãã次ã®
æ¹æ³ã«ãã€ãŠçæã§ããã ç¹ã«æ¬çºæã¯äžèšåå¿å·¥çšå³ã«ããåŒããã€
ååç©è£œé ã«ãã³ããšä¿®æ£æ³ãçšãããäžè¬åå¿
æ¹æ³ãšå¿ èŠãªå€ãã®äžéååç©ã¯æ¢ã«ç±³åœç¹èš±ç¬¬
4414213å·ã«èšèŒãããŠããããã®ç¹èš±ã¯åèãš
ããŠæ¬æ现æžã«å ããŠããã åŒããã€ååç©ã®äžè¬è£œé æ³ã¯å·¥çšå³ïŒã«ç€º
ãããåäžæ³ã®å€æ³ãšããŠã¿ãããã åèšã®è£œé å·¥çšå³ïŒã«ç€ºããäžè¬åææ³ã®R2ã
R5ãR6ãR7ãR9ãïœãããã³ïŒºã¯åŒã«å®çŸ©
ãããšããã§ãããã¯å¡©çŽ ã®æ§ãªããã²ã³ã
NHR9åã¯ïŒ®ïŒR7ïŒïŒCH2ïŒnXZã®ãã¥ãã§ãã
ããã¯ææ©åææ³ã«ç¥ãããŠããæ§ãªé¢è±åºã
äŸãã°èåç©ã®æ§ãªããã²ã³åç©ãã¡ã·ã¬ãŒãå
ã¯ãã·ã¬ãŒãçã瀺ãã äžè¬åææ³ã«ããåŒããã€ååç©ã®è£œé ã¯
åããã³åäžéååç©ããã®ãŸãŸåã¯çš®ã ã®
åå¿ã«äžæŽ»æ§ãªææ§æº¶åªã®ååšã®ãã¥ããã§å ç±
ããŠåŒããã€ååç©ã®è£œé ããæããé©åœãã
溶åªã«ã¯ãã³ãŒã³ããã«ãšã³ãããã©ããããã©
ã³ããžããã«ãšãŒãã«ããã¿ããŒã«ããããµããŒ
ã«ãã¡ã¿ããŒã«ããžã¡ããã·ãšã¿ã³ããšãã¬ã³ã°
ãªã³ãŒã«ããšã¿ããŒã«ããããããŒã«çããã
ãããããã«éå®ãããã®ã§ã¯ãªããé©åœãªåå¿
枩床ã¯çŽ60â150âã§ãããä»ã®è§Šåªåã¯çž®åå€
ã¯æ®éå¿ èŠãªããå¿ èŠãªäžéäœãšããã³ãšã¹ãã«
ïŒïŒã¯äžè¬ã«ã¢ããå解åå¿æ¡ä»¶ïŒNH4
OAcïŒã¢ã«ã³ãŒã«ïŒã®ããšã§äžéäœããçæ
ããããäžéäœã¯æ®éåé¢ãããªããçŽã¡ã«
é©åœãªäžéäœååç©ãšåå¿ããããããæ§é åŒ
ããã€äžéäœã¢ã·ã«ã·ã³ãã¡ãŒãååç©ã¯äžè¬
ã«ç¥ãããããŒãã³ããŒã²ã«çž®ååå¿æ¡ä»¶ãçšã
ãŠè£œé ããããäžè¬ã«é©åœããããããã³ãºã¢ã«
ãããïŒïŒãšïŒïŒïŒâãžã«ã«ããã«ååç©
ïŒïŒã¯çž®åãããŠãšãªãã 次ãã§åŒååç©ã¯ãµãæ§é ã«ããæ¹æ³å·¥çš
ãããã¶ããšã«ãã€ãŠé©åœããåŒã«è»¢åãã
ãããïŒR7ïŒïŒCH2ïŒnXZãªãã°ïŒïœïŒã«ç€º
ããšããïŒã§ããããClãªãã°ã¯ïŒïœïŒ
ã«ç€ºããšããååç©äžéäœãšåå¿ããŠãšãª
ãããNHR7ã§ããã°ã¯ïŒïœïŒã«ç€ºããšãã
ååç©äžéäœãšåå¿ããŠãšãªããæåŸã«
ã®ããããã§ããã°ã¯ã¢ã«ã³ãŒã«äžãããªãŠ
ã ããªãªããŒãã§é žåãããŠïŒïœïŒã«ç€ºããšãã
ãºã«ããªãã·ãçæç©ãšãªãã äžè¬åææ³ã®ãããã®å€æ³ãäžèšåå¿å·¥çšå³ã§
詳现ã«ç€ºãã å·¥çšå³ïŒã«ç€ºãããšããã¯ããã¢ã«ã«ããŒã«
ïŒïŒãããªã«ã ã¢ããïŒïŒåã¯ã¢ããã¢ã«ã«ã
ãŒã«ïŒïŒã®ãã¥ããããžã±ãã³åã¯ã¡ã«ãã©ã
ã®é žã®ãã¥ãããšåŠçããŠçããäžéäœïŒïŒïŒâ
ãžã«ã«ããã«ååç©ïŒVaâïœïŒããã³ããŠçž®å
ä¿®æ£æ¡ä»¶ïŒã¢ã³ã¢ããŠã ã¢ã»ããŒãïŒãšã¿ããŒ
ã«ïŒã§åŠçããåŸïŒ¡ãšïŒ£ã«ããããšããã·ã³ãã¡
ãŒãäžéäœïŒïŒãšåå¿ããåã¯ã®å æ°Žå解
ã«ããïœãšããåŸïŒ¢ã«ããããšããäžéäœ
ãšåå¿ãããŠæãåŒããã€çæç©ãããããã
åå¿å·¥çšå³ïŒã«ç€ºãåææ³ã¯ãžã±ãã³ã®äœ¿çšã瀺
ããããã€ãŠR2ãã¡ãã«ãšããããã¡ã«ãã©ã
ã®é žã¯å·¥çšå³ïŒã«ç€ºããšãã䜿çšã§ãããã¡ã«ã
ã©ã ã®é žã¯ã¡ã«ã¯ã€ã³ããã¯ã¹10ç5635ã828ã
ãŒãžïŒ1983ïŒã«èšèŒãããŠããã ååç©ã®R2ã¯ã¡ãã«ä»¥å€ã®ãã®ã§ããã C3O2ã·ã³ãœã³ãšããŠã®ã¡ã«ãã©ã ã®é žã®äœ¿çš
ã®æŽã«è©³çŽ°ã¯Y.ãªã€ã«ã¯ãã®J.Org.Chem.43ã
2087ïŒ1978ïŒã«ããã æ¬çºæååç©ã¯ã«ã«ã·ãŠã ã€ãªã³é»æ¢æŽ»æ§ãè
è¡ã«ããçµç¹å·å®³æå¶ããã³è¡å°æ¿åéæå¶ãªã©
ã®å€ãã®æå¹ãªè¬ççæ§è³ªããã€ããšãèŠåºãã
ãããã®è¬ççæ§è³ªã¯æ¬çºæååç©ã«ããå¿èè¡
管ç æ²»çã«ãããæçšæ§ã®åå ãšãªããšæãã
ãã詳述ããã°ã«ã«ã·ãŠã é»æ¢æŽ»æ§ã®ä»ã«èè¡é²
æ¢æŽ»æ§ããã³ïŒåã¯ïŒå°æ¿åéé²æ¢æ§ããã€åå
ç©ã¯å¿çèè¡ãé«è¡å§ãéæ¬ æ§è·è¡çããã³ïŒå
ã¯ïŒãã€è¡æ§å¿è麻çºã®æ²»çã«æçšãªç¹æã®çç©
åŠçãããã€ã«ããã€ã ã«ã«ã·ãŠã ã€ãªã³é²å ¥é®æã¯ã©ããã®èé¢å€§å
èãééèããã³æ°ç®¡ã®æ§ãªçš®ã ã®å¹³æ»çç³»ã«ã
ããŠç 究ããããäžè¬ã«æ¬çºæã®å¥œãŸããååç©
ã¯é¢é£ååç©äºã«ã«ãžãã³ãšåãåã¯æ¯èŒããŠæ¹
è¯ãããå¹åããã€ã«ã«ã·ãŠã é²å ¥é®æ掻æ§ãã
ã€ã æ¬çºæã®ããã°ããååç©ã¯èè¡å·å®³ããå¿è
çµç¹ãä¿è·ããè¬å¹ã瀺ãããéçºãããã€ã³ã
ããåã³ã€ã³ããè©Šéšã«ãã€ãŠãæ€ã¹ãããã
ïŒããŒãŒã³ãã«ã¬ãŒãã®Life Sci.ïŒ34ã1379
ïŒ1984ïŒåç §ïŒãã®è©Šéšã¯é«ãšãã«ã®ãŒãã¹ããš
ãŒãã®æŒžé²æžæ¶²æ³ãšèè¡å¿çå±€ã®èŽåœç现èå·å®³
éå§ãšã®éã®ç¥ãããé¢ä¿ãçšããããã®è©Šéšã®
çµæã¯æ¬çºæã®ååç©ãæèè¡äœçšã«å¹åããã
ãšã瀺ããŠããããã®æŽ»æ§ã¯èè¡ã«ãã€ãŠçãã
èªå·±æº¶è§£ä¿è·ãã§ããªãé¢é£äºã«ã«ãžãã³ããæ¬
çºæååç©ãæçã«åºå¥ããã çµå±æ¬çºæã®ååç©ã¯è¡å°æ¿æ©èœã®çš®ã ã®åœ¢æ
ãæå¹ã«æå¶ããããã®ä»£è¡šçãªå¹åã¯ã³ã©ãŒã²
ã³ã«ãã€ãŠãããè¡å°æ¿åéã«å¯Ÿããæ¬ååç©ã®
æå¶åã§ããã èŠããã«åèšè¬ççè©Šéšã«ãã€ãŠç€ºãããçç
åŠç掻æ§ãèæ ®ããã°æ¬çºæååç©ã¯é«è¡å§çãš
èè¡é¢é£çã«äœ¿çšããã«é©ããå¿èè¡ç®¡æ§ãã
ã€ããããã€ãŠæ¬çºæã®ä»ã®æ æ§ã¯é«è¡å§åã¯è
è¡é¢é£çã®æ²»çãèŠããåºä¹³åç©ã«åŒããã€å
åç©åã¯ãã®è£œè¬äžèš±å®¹ãããé žä»å å¡©ã®æå¹é
ãæäžããããšããæãäžèšåºä¹³åç©ã®çç¶æ¹å
æ³ã«é¢ããã äžè¬ã«æ¬çºæååç©ã¯é¢é£è¬äºããšãžãã³ãšå
æ§ã®æ¹æ³ã§æäžãããæ¯æ¥ã®çµå£è¬éã¯çŽ10ä¹è³
çŽ60mgã奜ãŸããã¯10ä¹è³20mgãæ¯æ¥ïŒä¹è³ïŒå
ã«åããŠæäžããã®ã§ãããããå Žåããå°éã§
ååãªæ²»çå¹æããããããããã倧éãå¿ èŠãª
å Žåããããèšåºçšã«ã¯è¬éãšæçšæ³ã¯å®å šãªå°
åçå€æãçšã幎什ãäœéãšæ£è ã®ç¶æ ãæäžæ¹
æ³ããã³ç æ°ã®ç¹æ§ãšè»œéãèæ ®ããŠåå調ç¯ã
ãå¿ èŠããããæ¬çºæååç©ã¯çµå£æäžã奜ãŸã
ãã æ¬æ现æžã§äœ¿ãâå šèº«çæäžâãšã¯çµå£ãçŽè ž
ããã³éçµå£ïŒå³ã¡çèå ãéèå ããã³ç®äžïŒ
æäžæ³ããããäžè¬ã«æ¬çºæã®ååç©ãçµå£æäž
ãããšããããã奜ãŸããæ¹æ³ã§ããããéçµå£
æäžããå°éã®è¬å€ãšåãå¹æãçããã«å€éã®
è¬å€ãå¿ èŠã§ãããããèšåºæ³ã«ããã°æ¬ååç©
ãå±éºãªåã¯ããã©ããªå¯äœçšãªãã«æå¹ãªé«è¡
å§ããã³ïŒåã¯ïŒé»è¡é²æ¢å¹æãçããæ¿åºŠã§æ
äžãããšããã æ²»ççã«æ¬ååç©ã¯äžè¬ã«åŒããã€ååç©å
ã¯ãã®è£œè¬çé žä»å å¡©ã®æå¹ãªé«è¡å§ããã³ïŒå
ã¯ïŒèè¡æå¶éãšè£œè¬äžèš±å®¹ãããåäœããæã
補è¬çµæç©ãšããŠäžããããããã®æ²»ççšã®è£œè¬
çµæç©ã¯æ¬çºæã®å°ãªããšãïŒååç©95ä¹è³0.5
ïŒ ãåºäœãæºåºäœåã¯æ¶²äœçšéå€ã®ïŒåã¯ïŒä»¥
äžãå¢éå€ãããã³ç¡æ¯ãäžæŽ»æ§è£œè¬äžèš±å®¹ãã
ã調åè£å©å€ããæãæ äœãšå ±ã«å«ãããã®è£œè¬
çµæç©ã¯æçšåäœåœ¢æ ã§ãããšãããå³ã¡æãæ²»
çåå¿ãçããæ§èšç®ãããè¬éã®éšååã¯åæ°
ã«çžåœããäžå®è¬éãå«ãç©ççåå¥åäœãã
ããæçšåäœã¯åäžè¬éã®ïŒãïŒãïŒåã¯ãã以
äžåã¯åäžè¬éã®1/2ã1/3åã¯ãã以äžãå«ãã
ãšãã§ãããåäžè¬éã¯äžå®æçšæ³ã«ããïŒåã¯
ïŒä»¥äžã®æçšåäœã®ïŒå䜿çšã«æ®éïŒæ¥ïŒãïŒã
ïŒåã¯ïŒåã«æäžãããæ¥éã®å šéšã1/2ã1/3ã
åã¯1/4ãæäžããŠæãæ²»çå¹æãçããã«åå
ãªéãå«ããšãããä»ã®æ²»çè¬ãå«ãŸããŠããŠã
ãããåäœè¬å€åœã掻æ§æåçŽïŒä¹è³50mgãå«ã
補è¬çµæç©ã奜ãŸãããæ®éé å€ãå£è é ãã«ã
ã»ã«ãç²æ«ãæ°Žæ§åã¯æ²¹æ§æžæ¿æ¶²ãã·ãããããš
ãªãã·ãŒã«å€ããã³æº¶æ¶²ãšããŠè£œé ãããã奜ãŸ
ããçµå£çšçµæç©ã¯é å€åã¯ã«ãã»ã«åœ¢ã§ãçµå
å€ïŒäŸãã°ã·ããããã¢ã«ã·ã¢ããŒã©ãã³ããœã«
ãããŒã«ããã©ã¬ã«ã³ãåã¯ããªããã«ãããªã
ã³ïŒãå¢éå€ïŒäŸãã°ä¹³ç³ãç ç³ãã³ãŒã³ã¹ã¿ãŒ
ããããé žã«ã«ã·ãŠã ããœã«ãããŒã«åã¯ã°ãªã·
ã³ïŒãæ»å€ïŒäŸãã°ã¹ãã¢ãªã³é žãã°ãã·ãŠã ã
ã¿ã«ã¯ãããªãšãã¬ã³ã°ãªã³ãŒã«åã¯ã·ãªã«ïŒã
厩å£å€ïŒäŸãã°æŸ±ç²ïŒããã³æ¹¿æœ€å€ïŒäŸãã°ã©ãŠ
ãªã«ç¡«é žãããªãŠã ïŒã®æ§ãªæ®éã®è³Šåœ¢å€ãå«ã
ã§ããããåŒååç©ãšæ®éã®è£œè¬è³Šåœ¢å€ãšã®æº¶
液åã¯æžæ¿æ¶²ã¯éè泚å°çšæ°Žæº¶æ¶²åã¯çèå 泚å°
çšæ²¹æ§æžæ¿æ¶²ã®æ§ãªéçµå£çšçµæç©ã«äœ¿ãããã
æãéæ床ãå®å®æ§ããã³éçµå£çšéã«å¯Ÿããé©
å¿æ§ããã€ãã®çµæç©ã¯æ°Žåã¯ã°ãªã»ãªã³ããã
ãã¬ã³ã°ãªã³ãŒã«ããã³ããªãšãã¬ã³ã°ãªã³ãŒã«
ã®æ§ãªå€äŸ¡èèªæã¢ã«ã³ãŒã«åã¯ãã®æ··åç©ãã
æã賊圢å€äžã«æŽ»æ§ååç©ã0.1ä¹è³10ééïŒ ãš
ãããŠãããããããªãšãã¬ã³ã°ãªã³ãŒã«ã¯æ°Žãš
ææ©æ¶²äœã®äž¡æ¹ã«å¯æº¶ã§ããçŽ200ä¹è³1500ã®å
åéããã€éæ®çºæ§æ®é液äœã®ããªãšãã¬ã³ã°ãª
ã³ãŒã«æ··åç©ããæãã å®æœäŸ æ¬çºæãæ§æããååç©ãšãã®è£œé æ³ã¯æ¬¡ã®å®
æœäŸãç¥ãããšã«ãã€ãŠååè«è§£ãããã§ãã
ããå®æœäŸã¯æ¬çºæãåã«äŸèšŒã®ããã®ãã®ã§ã
ããæ¬çºæã®ç¯å²ãéå®ãããã®ãšè§£éãã¹ãã§
ã¯ãªããç¹ã«æããªãéã枩床ã¯ãã¹ãŠææ°åºŠâ
ã§ç€ºããŠãããæ žç£æ°å ±é³ŽïŒNMRïŒã¹ãã¯ãã«
ç¹æ§ã¯æ¯èŒæšæºãšããŠããã©ã¡ãã«ã·ã©ã³
ïŒTMSïŒã«å¯Ÿããppmã§ããããããååŠã·ãã
ïŒÎŽïŒãããããããã³NMRã¹ãã¯ãã«ããŒã¿
ã®çš®ã ã®ã·ããã«ã€ãå ±åãããé¢ç©æ¯ã¯ååäž
ã®ç¹æ®å®èœåã®æ°ŽçŽ ååæ°ã«çžåœãããå€æ°æ§ã«
é¢ããã·ããã®ç¹æ§ã¯åºïŒéé ïŒbsïŒãïŒéé
ïŒïœïŒãå€éé ïŒïœïŒãïŒéé ïŒïœïŒãïŒéé ïŒé
ïŒddïŒãïŒéé ïŒïœïŒåã¯ïŒéé ïŒïœïŒãšããŠå ±
åããŠããã次ã®èšå·ãçšããïŒDMSOâd6ïŒã
ã«ããŠãããžã¡ãã«ãºã«ããªãã·ãïŒãCDCl3ïŒã
ãŠããã¯ãããã«ã ïŒä»ã¯æ®éã®ãšãããèµ€å€ç·
ïŒIRïŒã¹ãã¯ãã«èšè¿°ã¯å®èœåºåå®å€ããã€åžå
Vgæ³¢æ°ïŒcm-1ïŒã®ã¿ãå«ããIR枬å®ã¯çšéå€ãš
ããŠèåã«ãªãŠã ïŒKBrïŒãçšããŠè¡ãªã€ãã
ååç©ã¯ãã¹ãŠååå çŽ åæãããã äžéäœåæ  åŒããã€äžéäœ å®æœäŸ ïŒ ã¡ãã«ïŒâãïŒïŒâãããããšãã«ïŒã¡ãã¬ã³ã
âïŒâãªã¯ãœãã¿ããšãŒã ïŒâããããã³ãºã¢ã«ããã151gïŒ1.00ã¢ã«ïŒã
ã¡ãã«ã¢ã»ãã¢ã»ããŒã116gïŒ1.00ã¢ã«ïŒãæ°·é ¢é ž
10mlããããªãžã³ïŒmlããã³ãã³ãŒã³400mlã®æº¶
液ãïŒæééæµãããããã®éã«ãã€ãŒã³ã¹ã¿ãŒ
ã¯ç®¡ããžãŠæ°Ž21mlããšãåºãããæé»è²æº¶æ¶²ã倧
æ°æž©ã«å·ããšåºåãããéããšãŒãã«ã§æŽã€ãŠ
é»è²åºäœçæç©180gãããã液ããæŽã«23gã®
çæç©ãããŠå šçæç©203gïŒ82ïŒ ïŒã§ãã€ããè
ç¹145â146âïŒæç®èç¹158âïŒã¡ãŒã€ãŒãã®
ArzneimâForshïŒDrug ResearchïŒ31ã407
ïŒ1981ïŒåç §ïŒ å®æœäŸ ïŒ ãšãã«ïŒâãïŒïŒâãããããšãã«ïŒã¡ãã¬ã³ã
âïŒâãªã¯ãœãã¿ããšãŒã æ¬ååç©ã¯å®æœäŸïŒã®æ¹æ³ã«ããã¢ã«ã¹ã±ãŒã«
ã§è£œé ããããã¡ãã«ãšã¹ãã«ã®ä»£ãã«ãšãã«ã¢
ã»ãã¢ã»ããŒããçšããããšã¿ããŒã«ããåæ¶åº
ãããŠé»è²åºäœçæç©182gïŒ69ïŒ ïŒããããèç¹
103â106âïŒæç®èç¹110âïŒã«ãŒãšãã³ã®J.
Chem.SocïŒ83ã717ïŒ1903ïŒåç §ïŒ äžèšæ¹æ³ãçšã補é ããåŒããã€äžéäœã®è¿œ
å å®æœäŸãè¡šïŒã«ç€ºããŠããã
ã§ãããïŒã§ãããããååŠçµåã§ãããšãã«
éãã¯ïŒâã€ã³ããªã«åºã§ãããšããæ¡ä»¶ãã
ããã¯ç¡é¢ä¿ã«æ°ŽçŽ ãäœçŽã¢ã«ãã«åã¯äœçŽã¢
ã«ã³ãã·ãããšãã«âäœçŽã¢ã«ãã¬ã³åã¯ïŒâã€
ã³ããŒã«ããããã°ããïŒä¹è³ïŒã®çœ®æåºã§çœ®æ
ãããããšãã«ããæã矀ããããã°ããã æ¬çºæã®å¥œãŸããååç©ã¯åŒã«ãããŠR2ã
R5ãR6ããã³R7ãäœçŽã¢ã«ãã«ã§ããããã
ããåååã¯NR9ã§ããã€ïŒºãããšãã«ã§ãã
æ§ãªæ§é åŒããã€ãæã奜ãŸããååç©ã¯ïœãïŒ
ã§ããR7ãã¡ãã«ããããã€ïŒžããããååå
ã¯NR9ã§ããæ§ãªãã®ã§ããã æ¬çºæã®ååç©ã¯å åŠç°æ§äœãšããŠååšããã
ããã®ç°æ§äœã®ã©ã»ãæ··åç©äžŠã³ã«åã ã®å åŠç°
æ§äœèªèº«ãæ¬çºæã®ç¯å²å ã§ãããã©ã»ãæ··åç©
ã¯å åŠç掻æ§é žã§çæããããžãšã¹ããªãªã¡ã«å¡©
ãåé¢ããåŸå åŠç掻æ§å¡©åºã«è»¢åãæ»ãæ§ãªç¥
ãããæ¹æ³ã§åã ã®ç°æ§äœã«åé¢ã§ããã äžèšã®ãšããæ¬çºæã¯ãŸããã®åºæ¬ååç©ã®è£œ
è¬äžèš±å®¹ãããç¡æ¯å¡©ã«ãé¢ããããã®å¡©ã«ã¯æ
æ©ãšç¡æ©é žãäŸãã°å¡©é žãèåæ°ŽçŽ é žããªã³é žã
ç¡«é žãã¡ã¿ã³ã¹ã«ããªã³é žãé ¢é žãé ç³é žãä¹³
é žããã¯ãé žããããé žããã¬ã€ã³é žããœã«ãã³
é žãã¢ã³ãããé žããµãªãã«é žããã¿ã«é žããšã³
ãããã¯é žããªãã³ãé žçããèªå°ãããå¡©ãã
ããããããã«éå®ãããã®ã§ã¯ãªãã æ¬çºæã®ååç©ã¯é©åœãªåºçºç©è³ªã«å¿çšããã
ãã³ããŠïŒHantschïŒåæåå¿å€æ³ãçšãã次ã®
æ¹æ³ã«ãã€ãŠçæã§ããã ç¹ã«æ¬çºæã¯äžèšåå¿å·¥çšå³ã«ããåŒããã€
ååç©è£œé ã«ãã³ããšä¿®æ£æ³ãçšãããäžè¬åå¿
æ¹æ³ãšå¿ èŠãªå€ãã®äžéååç©ã¯æ¢ã«ç±³åœç¹èš±ç¬¬
4414213å·ã«èšèŒãããŠããããã®ç¹èš±ã¯åèãš
ããŠæ¬æ现æžã«å ããŠããã åŒããã€ååç©ã®äžè¬è£œé æ³ã¯å·¥çšå³ïŒã«ç€º
ãããåäžæ³ã®å€æ³ãšããŠã¿ãããã åèšã®è£œé å·¥çšå³ïŒã«ç€ºããäžè¬åææ³ã®R2ã
R5ãR6ãR7ãR9ãïœãããã³ïŒºã¯åŒã«å®çŸ©
ãããšããã§ãããã¯å¡©çŽ ã®æ§ãªããã²ã³ã
NHR9åã¯ïŒ®ïŒR7ïŒïŒCH2ïŒnXZã®ãã¥ãã§ãã
ããã¯ææ©åææ³ã«ç¥ãããŠããæ§ãªé¢è±åºã
äŸãã°èåç©ã®æ§ãªããã²ã³åç©ãã¡ã·ã¬ãŒãå
ã¯ãã·ã¬ãŒãçã瀺ãã äžè¬åææ³ã«ããåŒããã€ååç©ã®è£œé ã¯
åããã³åäžéååç©ããã®ãŸãŸåã¯çš®ã ã®
åå¿ã«äžæŽ»æ§ãªææ§æº¶åªã®ååšã®ãã¥ããã§å ç±
ããŠåŒããã€ååç©ã®è£œé ããæããé©åœãã
溶åªã«ã¯ãã³ãŒã³ããã«ãšã³ãããã©ããããã©
ã³ããžããã«ãšãŒãã«ããã¿ããŒã«ããããµããŒ
ã«ãã¡ã¿ããŒã«ããžã¡ããã·ãšã¿ã³ããšãã¬ã³ã°
ãªã³ãŒã«ããšã¿ããŒã«ããããããŒã«çããã
ãããããã«éå®ãããã®ã§ã¯ãªããé©åœãªåå¿
枩床ã¯çŽ60â150âã§ãããä»ã®è§Šåªåã¯çž®åå€
ã¯æ®éå¿ èŠãªããå¿ èŠãªäžéäœãšããã³ãšã¹ãã«
ïŒïŒã¯äžè¬ã«ã¢ããå解åå¿æ¡ä»¶ïŒNH4
OAcïŒã¢ã«ã³ãŒã«ïŒã®ããšã§äžéäœããçæ
ããããäžéäœã¯æ®éåé¢ãããªããçŽã¡ã«
é©åœãªäžéäœååç©ãšåå¿ããããããæ§é åŒ
ããã€äžéäœã¢ã·ã«ã·ã³ãã¡ãŒãååç©ã¯äžè¬
ã«ç¥ãããããŒãã³ããŒã²ã«çž®ååå¿æ¡ä»¶ãçšã
ãŠè£œé ããããäžè¬ã«é©åœããããããã³ãºã¢ã«
ãããïŒïŒãšïŒïŒïŒâãžã«ã«ããã«ååç©
ïŒïŒã¯çž®åãããŠãšãªãã 次ãã§åŒååç©ã¯ãµãæ§é ã«ããæ¹æ³å·¥çš
ãããã¶ããšã«ãã€ãŠé©åœããåŒã«è»¢åãã
ãããïŒR7ïŒïŒCH2ïŒnXZãªãã°ïŒïœïŒã«ç€º
ããšããïŒã§ããããClãªãã°ã¯ïŒïœïŒ
ã«ç€ºããšããååç©äžéäœãšåå¿ããŠãšãª
ãããNHR7ã§ããã°ã¯ïŒïœïŒã«ç€ºããšãã
ååç©äžéäœãšåå¿ããŠãšãªããæåŸã«
ã®ããããã§ããã°ã¯ã¢ã«ã³ãŒã«äžãããªãŠ
ã ããªãªããŒãã§é žåãããŠïŒïœïŒã«ç€ºããšãã
ãºã«ããªãã·ãçæç©ãšãªãã äžè¬åææ³ã®ãããã®å€æ³ãäžèšåå¿å·¥çšå³ã§
詳现ã«ç€ºãã å·¥çšå³ïŒã«ç€ºãããšããã¯ããã¢ã«ã«ããŒã«
ïŒïŒãããªã«ã ã¢ããïŒïŒåã¯ã¢ããã¢ã«ã«ã
ãŒã«ïŒïŒã®ãã¥ããããžã±ãã³åã¯ã¡ã«ãã©ã
ã®é žã®ãã¥ãããšåŠçããŠçããäžéäœïŒïŒïŒâ
ãžã«ã«ããã«ååç©ïŒVaâïœïŒããã³ããŠçž®å
ä¿®æ£æ¡ä»¶ïŒã¢ã³ã¢ããŠã ã¢ã»ããŒãïŒãšã¿ããŒ
ã«ïŒã§åŠçããåŸïŒ¡ãšïŒ£ã«ããããšããã·ã³ãã¡
ãŒãäžéäœïŒïŒãšåå¿ããåã¯ã®å æ°Žå解
ã«ããïœãšããåŸïŒ¢ã«ããããšããäžéäœ
ãšåå¿ãããŠæãåŒããã€çæç©ãããããã
åå¿å·¥çšå³ïŒã«ç€ºãåææ³ã¯ãžã±ãã³ã®äœ¿çšã瀺
ããããã€ãŠR2ãã¡ãã«ãšããããã¡ã«ãã©ã
ã®é žã¯å·¥çšå³ïŒã«ç€ºããšãã䜿çšã§ãããã¡ã«ã
ã©ã ã®é žã¯ã¡ã«ã¯ã€ã³ããã¯ã¹10ç5635ã828ã
ãŒãžïŒ1983ïŒã«èšèŒãããŠããã ååç©ã®R2ã¯ã¡ãã«ä»¥å€ã®ãã®ã§ããã C3O2ã·ã³ãœã³ãšããŠã®ã¡ã«ãã©ã ã®é žã®äœ¿çš
ã®æŽã«è©³çŽ°ã¯Y.ãªã€ã«ã¯ãã®J.Org.Chem.43ã
2087ïŒ1978ïŒã«ããã æ¬çºæååç©ã¯ã«ã«ã·ãŠã ã€ãªã³é»æ¢æŽ»æ§ãè
è¡ã«ããçµç¹å·å®³æå¶ããã³è¡å°æ¿åéæå¶ãªã©
ã®å€ãã®æå¹ãªè¬ççæ§è³ªããã€ããšãèŠåºãã
ãããã®è¬ççæ§è³ªã¯æ¬çºæååç©ã«ããå¿èè¡
管ç æ²»çã«ãããæçšæ§ã®åå ãšãªããšæãã
ãã詳述ããã°ã«ã«ã·ãŠã é»æ¢æŽ»æ§ã®ä»ã«èè¡é²
æ¢æŽ»æ§ããã³ïŒåã¯ïŒå°æ¿åéé²æ¢æ§ããã€åå
ç©ã¯å¿çèè¡ãé«è¡å§ãéæ¬ æ§è·è¡çããã³ïŒå
ã¯ïŒãã€è¡æ§å¿è麻çºã®æ²»çã«æçšãªç¹æã®çç©
åŠçãããã€ã«ããã€ã ã«ã«ã·ãŠã ã€ãªã³é²å ¥é®æã¯ã©ããã®èé¢å€§å
èãééèããã³æ°ç®¡ã®æ§ãªçš®ã ã®å¹³æ»çç³»ã«ã
ããŠç 究ããããäžè¬ã«æ¬çºæã®å¥œãŸããååç©
ã¯é¢é£ååç©äºã«ã«ãžãã³ãšåãåã¯æ¯èŒããŠæ¹
è¯ãããå¹åããã€ã«ã«ã·ãŠã é²å ¥é®æ掻æ§ãã
ã€ã æ¬çºæã®ããã°ããååç©ã¯èè¡å·å®³ããå¿è
çµç¹ãä¿è·ããè¬å¹ã瀺ãããéçºãããã€ã³ã
ããåã³ã€ã³ããè©Šéšã«ãã€ãŠãæ€ã¹ãããã
ïŒããŒãŒã³ãã«ã¬ãŒãã®Life Sci.ïŒ34ã1379
ïŒ1984ïŒåç §ïŒãã®è©Šéšã¯é«ãšãã«ã®ãŒãã¹ããš
ãŒãã®æŒžé²æžæ¶²æ³ãšèè¡å¿çå±€ã®èŽåœç现èå·å®³
éå§ãšã®éã®ç¥ãããé¢ä¿ãçšããããã®è©Šéšã®
çµæã¯æ¬çºæã®ååç©ãæèè¡äœçšã«å¹åããã
ãšã瀺ããŠããããã®æŽ»æ§ã¯èè¡ã«ãã€ãŠçãã
èªå·±æº¶è§£ä¿è·ãã§ããªãé¢é£äºã«ã«ãžãã³ããæ¬
çºæååç©ãæçã«åºå¥ããã çµå±æ¬çºæã®ååç©ã¯è¡å°æ¿æ©èœã®çš®ã ã®åœ¢æ
ãæå¹ã«æå¶ããããã®ä»£è¡šçãªå¹åã¯ã³ã©ãŒã²
ã³ã«ãã€ãŠãããè¡å°æ¿åéã«å¯Ÿããæ¬ååç©ã®
æå¶åã§ããã èŠããã«åèšè¬ççè©Šéšã«ãã€ãŠç€ºãããçç
åŠç掻æ§ãèæ ®ããã°æ¬çºæååç©ã¯é«è¡å§çãš
èè¡é¢é£çã«äœ¿çšããã«é©ããå¿èè¡ç®¡æ§ãã
ã€ããããã€ãŠæ¬çºæã®ä»ã®æ æ§ã¯é«è¡å§åã¯è
è¡é¢é£çã®æ²»çãèŠããåºä¹³åç©ã«åŒããã€å
åç©åã¯ãã®è£œè¬äžèš±å®¹ãããé žä»å å¡©ã®æå¹é
ãæäžããããšããæãäžèšåºä¹³åç©ã®çç¶æ¹å
æ³ã«é¢ããã äžè¬ã«æ¬çºæååç©ã¯é¢é£è¬äºããšãžãã³ãšå
æ§ã®æ¹æ³ã§æäžãããæ¯æ¥ã®çµå£è¬éã¯çŽ10ä¹è³
çŽ60mgã奜ãŸããã¯10ä¹è³20mgãæ¯æ¥ïŒä¹è³ïŒå
ã«åããŠæäžããã®ã§ãããããå Žåããå°éã§
ååãªæ²»çå¹æããããããããã倧éãå¿ èŠãª
å Žåããããèšåºçšã«ã¯è¬éãšæçšæ³ã¯å®å šãªå°
åçå€æãçšã幎什ãäœéãšæ£è ã®ç¶æ ãæäžæ¹
æ³ããã³ç æ°ã®ç¹æ§ãšè»œéãèæ ®ããŠåå調ç¯ã
ãå¿ èŠããããæ¬çºæååç©ã¯çµå£æäžã奜ãŸã
ãã æ¬æ现æžã§äœ¿ãâå šèº«çæäžâãšã¯çµå£ãçŽè ž
ããã³éçµå£ïŒå³ã¡çèå ãéèå ããã³ç®äžïŒ
æäžæ³ããããäžè¬ã«æ¬çºæã®ååç©ãçµå£æäž
ãããšããããã奜ãŸããæ¹æ³ã§ããããéçµå£
æäžããå°éã®è¬å€ãšåãå¹æãçããã«å€éã®
è¬å€ãå¿ èŠã§ãããããèšåºæ³ã«ããã°æ¬ååç©
ãå±éºãªåã¯ããã©ããªå¯äœçšãªãã«æå¹ãªé«è¡
å§ããã³ïŒåã¯ïŒé»è¡é²æ¢å¹æãçããæ¿åºŠã§æ
äžãããšããã æ²»ççã«æ¬ååç©ã¯äžè¬ã«åŒããã€ååç©å
ã¯ãã®è£œè¬çé žä»å å¡©ã®æå¹ãªé«è¡å§ããã³ïŒå
ã¯ïŒèè¡æå¶éãšè£œè¬äžèš±å®¹ãããåäœããæã
補è¬çµæç©ãšããŠäžããããããã®æ²»ççšã®è£œè¬
çµæç©ã¯æ¬çºæã®å°ãªããšãïŒååç©95ä¹è³0.5
ïŒ ãåºäœãæºåºäœåã¯æ¶²äœçšéå€ã®ïŒåã¯ïŒä»¥
äžãå¢éå€ãããã³ç¡æ¯ãäžæŽ»æ§è£œè¬äžèš±å®¹ãã
ã調åè£å©å€ããæãæ äœãšå ±ã«å«ãããã®è£œè¬
çµæç©ã¯æçšåäœåœ¢æ ã§ãããšãããå³ã¡æãæ²»
çåå¿ãçããæ§èšç®ãããè¬éã®éšååã¯åæ°
ã«çžåœããäžå®è¬éãå«ãç©ççåå¥åäœãã
ããæçšåäœã¯åäžè¬éã®ïŒãïŒãïŒåã¯ãã以
äžåã¯åäžè¬éã®1/2ã1/3åã¯ãã以äžãå«ãã
ãšãã§ãããåäžè¬éã¯äžå®æçšæ³ã«ããïŒåã¯
ïŒä»¥äžã®æçšåäœã®ïŒå䜿çšã«æ®éïŒæ¥ïŒãïŒã
ïŒåã¯ïŒåã«æäžãããæ¥éã®å šéšã1/2ã1/3ã
åã¯1/4ãæäžããŠæãæ²»çå¹æãçããã«åå
ãªéãå«ããšãããä»ã®æ²»çè¬ãå«ãŸããŠããŠã
ãããåäœè¬å€åœã掻æ§æåçŽïŒä¹è³50mgãå«ã
補è¬çµæç©ã奜ãŸãããæ®éé å€ãå£è é ãã«ã
ã»ã«ãç²æ«ãæ°Žæ§åã¯æ²¹æ§æžæ¿æ¶²ãã·ãããããš
ãªãã·ãŒã«å€ããã³æº¶æ¶²ãšããŠè£œé ãããã奜ãŸ
ããçµå£çšçµæç©ã¯é å€åã¯ã«ãã»ã«åœ¢ã§ãçµå
å€ïŒäŸãã°ã·ããããã¢ã«ã·ã¢ããŒã©ãã³ããœã«
ãããŒã«ããã©ã¬ã«ã³ãåã¯ããªããã«ãããªã
ã³ïŒãå¢éå€ïŒäŸãã°ä¹³ç³ãç ç³ãã³ãŒã³ã¹ã¿ãŒ
ããããé žã«ã«ã·ãŠã ããœã«ãããŒã«åã¯ã°ãªã·
ã³ïŒãæ»å€ïŒäŸãã°ã¹ãã¢ãªã³é žãã°ãã·ãŠã ã
ã¿ã«ã¯ãããªãšãã¬ã³ã°ãªã³ãŒã«åã¯ã·ãªã«ïŒã
厩å£å€ïŒäŸãã°æŸ±ç²ïŒããã³æ¹¿æœ€å€ïŒäŸãã°ã©ãŠ
ãªã«ç¡«é žãããªãŠã ïŒã®æ§ãªæ®éã®è³Šåœ¢å€ãå«ã
ã§ããããåŒååç©ãšæ®éã®è£œè¬è³Šåœ¢å€ãšã®æº¶
液åã¯æžæ¿æ¶²ã¯éè泚å°çšæ°Žæº¶æ¶²åã¯çèå 泚å°
çšæ²¹æ§æžæ¿æ¶²ã®æ§ãªéçµå£çšçµæç©ã«äœ¿ãããã
æãéæ床ãå®å®æ§ããã³éçµå£çšéã«å¯Ÿããé©
å¿æ§ããã€ãã®çµæç©ã¯æ°Žåã¯ã°ãªã»ãªã³ããã
ãã¬ã³ã°ãªã³ãŒã«ããã³ããªãšãã¬ã³ã°ãªã³ãŒã«
ã®æ§ãªå€äŸ¡èèªæã¢ã«ã³ãŒã«åã¯ãã®æ··åç©ãã
æã賊圢å€äžã«æŽ»æ§ååç©ã0.1ä¹è³10ééïŒ ãš
ãããŠãããããããªãšãã¬ã³ã°ãªã³ãŒã«ã¯æ°Žãš
ææ©æ¶²äœã®äž¡æ¹ã«å¯æº¶ã§ããçŽ200ä¹è³1500ã®å
åéããã€éæ®çºæ§æ®é液äœã®ããªãšãã¬ã³ã°ãª
ã³ãŒã«æ··åç©ããæãã å®æœäŸ æ¬çºæãæ§æããååç©ãšãã®è£œé æ³ã¯æ¬¡ã®å®
æœäŸãç¥ãããšã«ãã€ãŠååè«è§£ãããã§ãã
ããå®æœäŸã¯æ¬çºæãåã«äŸèšŒã®ããã®ãã®ã§ã
ããæ¬çºæã®ç¯å²ãéå®ãããã®ãšè§£éãã¹ãã§
ã¯ãªããç¹ã«æããªãéã枩床ã¯ãã¹ãŠææ°åºŠâ
ã§ç€ºããŠãããæ žç£æ°å ±é³ŽïŒNMRïŒã¹ãã¯ãã«
ç¹æ§ã¯æ¯èŒæšæºãšããŠããã©ã¡ãã«ã·ã©ã³
ïŒTMSïŒã«å¯Ÿããppmã§ããããããååŠã·ãã
ïŒÎŽïŒãããããããã³NMRã¹ãã¯ãã«ããŒã¿
ã®çš®ã ã®ã·ããã«ã€ãå ±åãããé¢ç©æ¯ã¯ååäž
ã®ç¹æ®å®èœåã®æ°ŽçŽ ååæ°ã«çžåœãããå€æ°æ§ã«
é¢ããã·ããã®ç¹æ§ã¯åºïŒéé ïŒbsïŒãïŒéé
ïŒïœïŒãå€éé ïŒïœïŒãïŒéé ïŒïœïŒãïŒéé ïŒé
ïŒddïŒãïŒéé ïŒïœïŒåã¯ïŒéé ïŒïœïŒãšããŠå ±
åããŠããã次ã®èšå·ãçšããïŒDMSOâd6ïŒã
ã«ããŠãããžã¡ãã«ãºã«ããªãã·ãïŒãCDCl3ïŒã
ãŠããã¯ãããã«ã ïŒä»ã¯æ®éã®ãšãããèµ€å€ç·
ïŒIRïŒã¹ãã¯ãã«èšè¿°ã¯å®èœåºåå®å€ããã€åžå
Vgæ³¢æ°ïŒcm-1ïŒã®ã¿ãå«ããIR枬å®ã¯çšéå€ãš
ããŠèåã«ãªãŠã ïŒKBrïŒãçšããŠè¡ãªã€ãã
ååç©ã¯ãã¹ãŠååå çŽ åæãããã äžéäœåæ  åŒããã€äžéäœ å®æœäŸ ïŒ ã¡ãã«ïŒâãïŒïŒâãããããšãã«ïŒã¡ãã¬ã³ã
âïŒâãªã¯ãœãã¿ããšãŒã ïŒâããããã³ãºã¢ã«ããã151gïŒ1.00ã¢ã«ïŒã
ã¡ãã«ã¢ã»ãã¢ã»ããŒã116gïŒ1.00ã¢ã«ïŒãæ°·é ¢é ž
10mlããããªãžã³ïŒmlããã³ãã³ãŒã³400mlã®æº¶
液ãïŒæééæµãããããã®éã«ãã€ãŒã³ã¹ã¿ãŒ
ã¯ç®¡ããžãŠæ°Ž21mlããšãåºãããæé»è²æº¶æ¶²ã倧
æ°æž©ã«å·ããšåºåãããéããšãŒãã«ã§æŽã€ãŠ
é»è²åºäœçæç©180gãããã液ããæŽã«23gã®
çæç©ãããŠå šçæç©203gïŒ82ïŒ ïŒã§ãã€ããè
ç¹145â146âïŒæç®èç¹158âïŒã¡ãŒã€ãŒãã®
ArzneimâForshïŒDrug ResearchïŒ31ã407
ïŒ1981ïŒåç §ïŒ å®æœäŸ ïŒ ãšãã«ïŒâãïŒïŒâãããããšãã«ïŒã¡ãã¬ã³ã
âïŒâãªã¯ãœãã¿ããšãŒã æ¬ååç©ã¯å®æœäŸïŒã®æ¹æ³ã«ããã¢ã«ã¹ã±ãŒã«
ã§è£œé ããããã¡ãã«ãšã¹ãã«ã®ä»£ãã«ãšãã«ã¢
ã»ãã¢ã»ããŒããçšããããšã¿ããŒã«ããåæ¶åº
ãããŠé»è²åºäœçæç©182gïŒ69ïŒ ïŒããããèç¹
103â106âïŒæç®èç¹110âïŒã«ãŒãšãã³ã®J.
Chem.SocïŒ83ã717ïŒ1903ïŒåç §ïŒ äžèšæ¹æ³ãçšã補é ããåŒããã€äžéäœã®è¿œ
å å®æœäŸãè¡šïŒã«ç€ºããŠããã
ãè¡šã
ãšãã«
ïŒ 4âããã ãžã¡ãã«
ã¢ãããš
ãã«
 åŒããã€äžéäœ å®æœäŸ ïŒ ïŒâã¯ãããããã«ã¢ã»ãã¢ã»ããŒãïŒVaïŒ ïŒâã¯ãããããããŒã«47.3gïŒ0.50ã¢ã«ïŒãšæ¥
觊éã®ããªãšãã«ã¢ãã³ã«65âã§ãžã±ãã³42g
ïŒ0.50ã¢ã«ïŒã滎å ãå®äºåŸåå¿æ··åç©ã65âã§
ïŒæéæªæãããèžçããŠéæ液äœçæç©72.9g
ïŒ82ïŒ ïŒãããã150mmã«ããã沞ç¹78â85âã å®æœäŸ 10 ãïŒâïŒããã«ãã«ã ã¢ããïŒãããã«ãã¡ã
ã«ã¢ã»ãã¢ã»ããŒãïŒVbïŒ ä¹Ÿç¥ã¢ã»ããããªã«200mläžã®ïŒâã¢ãããã
ãããŒã«37.6gïŒïŒžïŒ0.50ã¢ã«ïŒã®æº¶æ¶²ã«ïœâãã
ã«ãããã€ã69.6gïŒ0.56ã¢ã«ïŒãå ã16æééæµ
ãããã溶液ãç空æ¿çž®ããŠæ°Ž150mlãå ãæ··å
ç©ãæ°Žé žåãããªãŠã ã§ã¢ã«ã«ãªæ§ãšãããå¡©å
ã¡ãã¬ã³ã§æœåºãæœåºæ¶²ãæ¿çž®ããŠç²ããããã·
ãããã«ç¬¬ïŒã¢ãã³47.2gãããŠãããã100mlã®
ãšãã«ããªãŒã¡ãŒãã«ãã宀枩ã§äžå€æŸçœ®ããåŸ
æ®çºç©è³ªãç空é€å»ãããæ®æž£ã®ã¯ãŒã²ã«ããŒã«
èžçïŒæ²žç¹126âïŒ1.2mmïŒã¯éæ液ããªã«ã ã¢ã
ãäžéäœïŒïŒ26.9gïŒããåç34ïŒ ïŒãããã ããªã«ã ã¢ããã0.5mlã®ããªãšãã«ã¢ãã³ãš
æ··åããåŸãžã±ãã³14.2gïŒ0.17ã¢ã«ïŒããã¥ãã«
æªæåå¿æ··åç©ã«å ããããžã±ãã³åå¿äžã¯æ°·æµŽ
ãçšãåå¿ãå·ããã10ååŸã«æ·»å ãçµãæŽã«30
å宀枩ã§ãªã¬ã³ãžæº¶æ¶²ãæªæããŠVbãããŠãã
ãã¯ç²Ÿè£œããã«æ¬¡å·¥çšã«äœ¿çšããã å®æœäŸ 11 ïŒâããïŒâãïŒïŒ®âã¡ãã«ââããšãã«ïŒã¢ã
ãããšãã«ãâNâ²âïŒããšãã«ã¡ãã«ïŒã¢ããã
ãããã«ãã¡ãã«ã¢ã»ãã¢ã»ããŒãïŒVcïŒ ãã®äžéVcååç©ã¯éåžžçæç©ååç©ãžã®è»¢
åçŽåãã®å Žã§çæãããã âã¡ãã«ââããšãã«ââããšãã«ã¡ã
ã«âãšãã¬ã³ãžã¢ãã³ïŒïŒ103.gïŒ42.9ããªã¢
ã«ïŒãïŒâã¯ãããããããŒã«4.73gïŒ50.0ããªã¢
ã«ïŒã埮ç²ç çé žã«ãªãŠã 5.9gïŒ43.ããªã¢ã«ïŒã
ãã³ããåãããªãŠã ã®æ¥è§ŠéïŒçŽ25mgïŒã®æ··å
ç©ã75mlã®ã¢ã»ããããªã«ã«ãšãïŒæ¥ééæµãã
ããæ··åç©ãç空æ¿çž®ãæ®æž£ãå¡©åã¡ãã¬ã³äžã«
ãšãæ°Žã10ïŒ HCl氎溶液ïŒÏ ïŒÏ ïŒãæ°Žã10ïŒ
NaOH氎溶液ïŒÏïŒÏ ïŒãæ°Žããã³å¡©æº¶æ¶²ã§é 次
æŽã€ããçé žãããªãŠã äžã§ä¹Ÿç¥ããåŸæº¶åªãç
空é€å»ããŠæ·¡é»è²æ²¹13.3gãããããã®ç©è³ªãã
ã©ãã·ãŠã¯ãããã°ã©ãïŒã·ãªã«ïŒïŒïŒ ã¡ã¿ããŒ
ã«ïŒã¯ãããã«ã ïŒãããŠç¡è²æ²¹ãšããŠäžéäœ
ååç©5.5gïŒ41ïŒ ïŒããããäžéäœæ²¹ã®å°éšåã
ãªãã¶ã¬ãŒãå¡©ã«è»¢åãããïŒèç¹100â102âïŒ Vcçæç©ã¯100âã«å ç±ãã油济äžã®çææ²¹
ïŒæº¶åªäœ¿çšããïŒã«åœéã®ãžã±ãã³ãïŒæ»Žã¥ã€å
ããŠãã®å Žã§çæããã å®æœäŸ 12 ïŒâãâïŒããšãã«ã¡ãã«ïŒâNâ²âãïŒâïŒããš
ãã«ããªïŒãšãã«ãã¢ããããããã«ã¡ãã«ã¢
ã»ãã¢ã»ããŒãïŒVcïŒ ãã®äžéäœã¯å®æœäŸ11ã«èšèŒãããšåãæ¹æ³ã
çšããããåºçºç©è³ªãšããŠïŒ®âããšãã«ã¡ãã«â
Nâ²âããšãã«ããªâãšãã¬ã³ãžã¢ãã³ïŒïŒã
çšããŠãã®å Žã§çæãããç²åå¿æ²¹ãã¯ãŒã²ã«ã
ãŒã«èžçããŠäžéäœååç©ãåç58ïŒ ã§ããã
沞ç¹0.1mmã«ãããŠ170âãé©åœããVcçæç©ã¯
äžéäœæ²¹ããžã±ãã³ã§åŠçããŠãã®å Žã§çæã
ãã  å®æœäŸã®äžéäœ å®æœäŸ 13 ïŒïŒâã¯ãããããã«ïŒã¡ãã«ïŒïŒïŒâãžãã
ãâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããš
ãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬ãŒã
ïŒïœïŒ ã¢ã³ã¢ããŠã ã¢ã»ããŒã3.85gïŒ50.0ããªã¢ã«ïŒ
ãïŒâã¯ãããããã«ã¢ã»ãã¢ã»ããŒã8.15gïŒå®
æœäŸïŒã50.0ããªã¢ã«ïŒãšç¡æ°Žãšã¿ããŒã«50mlã®
溶液ã«å ãçªçŽ ã®ããšã§ïŒæééæµããã次ãã§
ïŒâããããã³ãºã¢ã«ããããšã¡ãã«ã¢ã»ãã¢ã»
ããŒã12.5gïŒ50.0ããªã¢ã«ïŒã®çž®åã§è£œé ããã¡
ãã«ïŒâãïŒïŒâãããããšãã«ïŒã¡ãã¬ã³ãâïŒ
âãªã¯ãœãã¿ããšãŒãïŒå®æœäŸïŒåç §ïŒãå ãã
ãé»è²æº¶æ¶²ãæŽã«12æééæµãããã宀枩ã«å·åŽ
ã溶åªãç空é€å»ããŠæ®æž£ããšã¿ããŒã«ããåæ¶
åºãããŠæãïœçæç©ãé»è²åºäœãšããŠããã
èç¹125â130°ã NMRïŒDMSOâd6ïŒïŒ2.04ïŒïŒïŒïœïŒïŒ2.35ïŒïŒïŒ
ïœïŒïŒ3.42ïŒïŒïŒïœïŒ6.5HzïŒïŒ3.64ïŒïŒïŒïœïŒïŒ4.20
ïŒïŒïŒïœïŒ6.3HzïŒïŒ5.07ïŒïŒïŒïœïŒïŒ7.40ïŒïŒïŒ
ïœïŒïŒ7.64ïŒïŒïŒïœïŒïŒ8.05ïŒïŒïŒïœïŒã IRïŒKBrïŒïŒ705ã1100ã1120ã1215ã1350ã
1490ã1530ã1650ã1685ã1700ã3370ã å®æœäŸ 14 ãïŒâïŒããã«ã¢ããïŒãããã«ãã¡ãã«ïŒïŒ
ïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâ
ãããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ã
ãã·ã¬ãŒãïŒïœïŒ ïœâããã«ãã«ã ã¢ãããããã«ã¢ã»ãã¢ã»ã
ãŒã23.1gïŒVb.0.10ã¢ã«ïŒã250mlã®ç¡æ°Žãšã¿ããŒ
ã«ã«æº¶æ¶²ãšãããã«ã¢ã³ã¢ããŠã ã¢ã»ããŒã7.7g
ïŒ0.10ã¢ã«ïŒãå ããããã溶液ãçªçŽ ã®ããšã§
ïŒæééæµããããã¡ãã«ïŒâãïŒïŒâãããããš
ãã«ïŒã¡ãã¬ã³ãâïŒâãªã¯ãœãã¿ããšãŒã24.9g
ïŒ0.10ã¢ã«ãïŒãå ãé»è²æ¶²ã17æééæµãã
ããåå¿æ··åç©ãç空æ¿çž®ããŠæé»è²æ¶²äœç²
57gãããããã®æ®ç液ãç¡æ°Žã¡ã¿ããŒã«500ml
äžã«ãšãããã«æ¿HCl8.3mlïŒ0.10ã¢ã«ïŒãå ãã
液ãçªçŽ ã®ããšã§éæµããã24æéåŸæ¶²ã宀枩ã«
å·ãç空æ¿çž®ãããããç©è³ªãå¡©åã¡ãã¬ã³äžã«
ãšãæœåºæ¶²ãæ°Žé žåã¢ã³ã¢ããŠã 液ãæ°Žããã³å¡©
溶液ã§æŽã€ããå¡©åã¡ãã¬ã³æœåºæ¶²ã䜵ããŠ
MgSO4ã§ä¹Ÿç¥ãéã液ãç空æ¿çž®ããŠæé»
è²æ²¹45.8gãããããã©ãã·ãŠã¯ãããã°ã©ã
ïŒã·ãªã«ïŒ5gã¡ã¿ããŒã«ïŒã¯ãããã«ã ïŒã«ãã
粟補ããŠé»è²æ²¹çæç©b16.9gïŒ38ïŒ ïŒãããã
ç¹æ§ãæ€ã¹ãããæ²¹ã®å°éããã·ã¬ãŒãå¡©ã«å€ã
ã¢ã»ããããªã«ããåçµæ¶ããŠé»è²åºäœãããã
èç¹142â146°ã åŒããã€äžéäœ åŒããã€ã¢ããååç©ã®å€ãã¯åžè²©ãããŠã
ããæ®ãã©ã¯ææ©åæé¢ä¿è ã«ãã€ãŠç¥ãããŠã
ãå ¬åŒæ¹æ³ã«ãã€ãŠè£œé ã§ãããç±³åœç¹èš±ç¬¬
4381401å·ãåç §ãããããåŒããã€å¿ èŠãªäž
éååç©ã®å€ãã¯äžèšåææ³ã«ãã€ãŠç€ºãããŠã
ãäžè¬åŒã«ãã補é ã§ããã å®æœäŸ 15 åŒããã€ååç©ã®äžè¬è£œé æ³ ç±³åœç¹èš±ç¬¬4381401å·ã®æ§ãªåŸæ¥æç®ã«ããã
ãé©åœãããªããµãŸãªãžãã³ïŒå®æœäŸ17ã18ãå
ç §ïŒã®åœã¢ã«éïŒ50â100ããªã¢ã«ïŒãã¢ããªã³å¡©
é žå¡©ããã³ïŒåã¯ïŒããªããšããŒã«ããã³æ¥è§Šé
ã®å¡©åãªããŠã ïŒåå¿é床ãå¢ãå¯æç©ãæå°ãš
ããããåå¿æ··åç©ã«å ããïŒãçªçŽ é°å²æ°ã®ã
ãšã§150â170âã«ä¿ã€ã油济äžã§å ç±æªæããã
油济枩床ã«éããåŸå解ããããã¬ã¹ãçºçã
ããïŒâ24æéåŸïŒã¬ã¹çºçåæ¢åã¯ç²åå¿æ··å
ç©ã®TLCåæã«ãã決å®ããïŒå 容ç©ã宀枩ãŸ
ã§å·ããããçªçŽ ã§ããçæååç©ïŒãžã¢ãã³
å¡©é žå¡©ååç©ïŒããšã¿ããŒã«ïŒãšãŒãã«æ··å液ã
ãåæ¶åºç²Ÿè£œãããã¢ãããšãã«ãµã«ãã¢ã€ã
ïŒïŒïŒ³ïŒã¯6.5ãšã¿ããŒã«æ§HClãšåŠçããŠã
ã®å¡©é žå¡©ã«å€ããåŸãšãã«ãšãŒãã«æ··å液ããå
æ¶åºãããã å®æœäŸ 16 âã¡ãã«âïŒâïŒããšãã«ããªïŒãããã³ã¢
ãã³å¡©é žå¡© å®æœäŸ15ã®æ¹æ³ã«ãããŠãªããµãŸãªãžãã³ã®ä»£
ãã«ãªããµãžãã³ãçšããŠãã®ååç©ã補é ã
ãã ããªããšããŒã«2.75gïŒ25.0ããªã¢ã«ïŒãããã©
ãããâïŒâã¡ãã«âïŒïŒšâïŒïŒïŒâãªããµãžã³
âïŒâãªã³2.88gïŒ25.0ããªã¢ã«ïŒãå®æœäŸ19ïŒã
ãã³æ¥è§ŠéïŒçŽïŒmgïŒã®å¡©åãªããŠã ã®æ··åç©ã
170°ã®æ²¹æµŽäžã§çªçŽ ã®ããšã§å ç±ãããçŽïŒæé
åŸé»è²æ¶²ã宀枩ãŸã§å·ãã¯ãŒã²ã«ããŒã«èžçã
ïŒæ²žç¹85°ïŒ0.3mmïŒã«ãã粟補ããŠéæ液äœçæ
ç©3.4gïŒ72ïŒ ïŒããããå°éè©Šæããšãå¡©é žå¡©ã«
å€ããšã¿ããŒã«ïŒãšãŒãã«ããåæ¶åºãããŠç¡è²
çœè²åºäœããããèç¹119â121âã å®æœäŸ 17 ïŒâïŒããšãã«ã¡ãã«ïŒâïŒâãªããµãŸãªãžãã³
ïŒR7ïŒCH2PhïŒïŒåŒååç©è£œé çšäžéäœïŒ 也ç¥THF100mläžã«æ°ŽçŽ åãããªãŠã ïŒ0.55ã¢
ã«ããããµã³æŽæµããïŒå·ïŒæ°·æµŽïŒæžæ¿æ¶²ãçªçŽ
é°å²æ°ã®ããšã§æªæããªãã10ïŒ1THFïŒ
DMF500mlã滎å ãããããç°è²æžæ¿æ¶²ã宀枩ã«
ãããã24æéæªæããããçœè²æžæ¿æ¶²ã«ãã³ãž
ã«ãããã€ã66mlïŒ0.056ã¢ã«ïŒãå ã宀枩ã§24
æéæªæãããåå¿æ··åç©ã«æ³šæããŠ26mlã®æ°Žã
å ããæ··åç©ãæ¿çž®ã500mlã®æ°Žäžã«æ³šå ¥ããã
å¡©åã¡ãã¬ã³ã§æœåºãæœåºæ¶²ã䜵ãæ°Žãšå¡©æº¶æ¶²ã§
æŽãMgSO4äžã§ä¹Ÿç¥ãç空æ¿çž®ããŠé»è²æ²¹104g
ãããããããã¯ãŒã²ã«ããŒã«èžçïŒæ²žç¹100°ïŒ
0.1mmïŒã§ç²Ÿè£œãç¡è²æ¶²äœçæç©81gïŒåç92ïŒ ïŒ
ããããããã宀枩ã§æŸçœ®ãããšç¡è²åºäœãšãªã€
ããèç¹76â78âã å®æœäŸ 18 ïŒâãïŒâïŒããšãã«ããªïŒãšãã«ãâïŒâãªã
ãµãŸãªãžãã³ïŒR7ïŒCH2CH2SPhïŒ å®æœäŸ17ãšåæ§ã®æ¹æ³ãå埩ãããããã³ãžã«
ãããã€ãã®ä»£ãã«ããã¢ãšãã«ããšãã«ãµã«ã
ã¢ã€ããçšãããã¯ãããã°ã©ãïŒã·ãªã«ïŒ
CHCl3ïŒã«ããé»è²æ²¹çæç©ãªããµãŸãªãžãã³
ïŒ17ïŒ ïŒãããã å®æœäŸ 19 ããã©ãããâïŒâã¡ãã«â2HâïŒïŒïŒâãª
ããµãžã³âïŒâãªã³ïŒR7ïŒCH3ïŒ ä¹Ÿç¥THF50mläžã«ãããµã³æŽæµåŸã®æ°ŽçŽ åã
ããªãŠã ïŒ0.10ã¢ã«ïŒã®æžæ¿æ¶²ãçªçŽ ã®ããšã§æª
æããªããTHF50mläžã«ããã©ãããâïŒïŒšâ
ïŒïŒïŒâãªããµãžã³âïŒâãªã³8.20gïŒ0.0812ã¢
ã«ïŒã®æº¶æ¶²ããã¥ãã«å ãããããæžæ¿æ¶²ã宀枩
ã§ïŒæéæªæåŸããåã¡ãã«28gïŒ0.02ã¢ã«ïŒãå
ãæ··åç©ãäžå€æªæãããåå¿æ··åç©ã«æ°ŽïŒmlã
å ã液ã塩溶液500mlã«æ³šå ¥ããã液ãé£ç¶ïŒæ¥
éå¡©åã¡ãã¬ã³ã§æœåºãææ©éšåãæ¿çž®ããŠç²ç
æç©7.8gããããã¯ãŒã²ã«ããŒã«èžçïŒæ²žç¹
101°ïŒ0.4mmïŒã«ãã粟補ããŠéæ液äœçæç©6.7g
ïŒ72ïŒ ïŒãããããã®äžéäœãå¿çšãäžèšæ¹æ³ã«
ãã€ãŠè£œé ããåŒããã€äžéã®è¿œå äŸãè¡šïŒã«
瀺ãã
ïŒ 4âããã ãžã¡ãã«
ã¢ãããš
ãã«
 åŒããã€äžéäœ å®æœäŸ ïŒ ïŒâã¯ãããããã«ã¢ã»ãã¢ã»ããŒãïŒVaïŒ ïŒâã¯ãããããããŒã«47.3gïŒ0.50ã¢ã«ïŒãšæ¥
觊éã®ããªãšãã«ã¢ãã³ã«65âã§ãžã±ãã³42g
ïŒ0.50ã¢ã«ïŒã滎å ãå®äºåŸåå¿æ··åç©ã65âã§
ïŒæéæªæãããèžçããŠéæ液äœçæç©72.9g
ïŒ82ïŒ ïŒãããã150mmã«ããã沞ç¹78â85âã å®æœäŸ 10 ãïŒâïŒããã«ãã«ã ã¢ããïŒãããã«ãã¡ã
ã«ã¢ã»ãã¢ã»ããŒãïŒVbïŒ ä¹Ÿç¥ã¢ã»ããããªã«200mläžã®ïŒâã¢ãããã
ãããŒã«37.6gïŒïŒžïŒ0.50ã¢ã«ïŒã®æº¶æ¶²ã«ïœâãã
ã«ãããã€ã69.6gïŒ0.56ã¢ã«ïŒãå ã16æééæµ
ãããã溶液ãç空æ¿çž®ããŠæ°Ž150mlãå ãæ··å
ç©ãæ°Žé žåãããªãŠã ã§ã¢ã«ã«ãªæ§ãšãããå¡©å
ã¡ãã¬ã³ã§æœåºãæœåºæ¶²ãæ¿çž®ããŠç²ããããã·
ãããã«ç¬¬ïŒã¢ãã³47.2gãããŠãããã100mlã®
ãšãã«ããªãŒã¡ãŒãã«ãã宀枩ã§äžå€æŸçœ®ããåŸ
æ®çºç©è³ªãç空é€å»ãããæ®æž£ã®ã¯ãŒã²ã«ããŒã«
èžçïŒæ²žç¹126âïŒ1.2mmïŒã¯éæ液ããªã«ã ã¢ã
ãäžéäœïŒïŒ26.9gïŒããåç34ïŒ ïŒãããã ããªã«ã ã¢ããã0.5mlã®ããªãšãã«ã¢ãã³ãš
æ··åããåŸãžã±ãã³14.2gïŒ0.17ã¢ã«ïŒããã¥ãã«
æªæåå¿æ··åç©ã«å ããããžã±ãã³åå¿äžã¯æ°·æµŽ
ãçšãåå¿ãå·ããã10ååŸã«æ·»å ãçµãæŽã«30
å宀枩ã§ãªã¬ã³ãžæº¶æ¶²ãæªæããŠVbãããŠãã
ãã¯ç²Ÿè£œããã«æ¬¡å·¥çšã«äœ¿çšããã å®æœäŸ 11 ïŒâããïŒâãïŒïŒ®âã¡ãã«ââããšãã«ïŒã¢ã
ãããšãã«ãâNâ²âïŒããšãã«ã¡ãã«ïŒã¢ããã
ãããã«ãã¡ãã«ã¢ã»ãã¢ã»ããŒãïŒVcïŒ ãã®äžéVcååç©ã¯éåžžçæç©ååç©ãžã®è»¢
åçŽåãã®å Žã§çæãããã âã¡ãã«ââããšãã«ââããšãã«ã¡ã
ã«âãšãã¬ã³ãžã¢ãã³ïŒïŒ103.gïŒ42.9ããªã¢
ã«ïŒãïŒâã¯ãããããããŒã«4.73gïŒ50.0ããªã¢
ã«ïŒã埮ç²ç çé žã«ãªãŠã 5.9gïŒ43.ããªã¢ã«ïŒã
ãã³ããåãããªãŠã ã®æ¥è§ŠéïŒçŽ25mgïŒã®æ··å
ç©ã75mlã®ã¢ã»ããããªã«ã«ãšãïŒæ¥ééæµãã
ããæ··åç©ãç空æ¿çž®ãæ®æž£ãå¡©åã¡ãã¬ã³äžã«
ãšãæ°Žã10ïŒ HCl氎溶液ïŒÏ ïŒÏ ïŒãæ°Žã10ïŒ
NaOH氎溶液ïŒÏïŒÏ ïŒãæ°Žããã³å¡©æº¶æ¶²ã§é 次
æŽã€ããçé žãããªãŠã äžã§ä¹Ÿç¥ããåŸæº¶åªãç
空é€å»ããŠæ·¡é»è²æ²¹13.3gãããããã®ç©è³ªãã
ã©ãã·ãŠã¯ãããã°ã©ãïŒã·ãªã«ïŒïŒïŒ ã¡ã¿ããŒ
ã«ïŒã¯ãããã«ã ïŒãããŠç¡è²æ²¹ãšããŠäžéäœ
ååç©5.5gïŒ41ïŒ ïŒããããäžéäœæ²¹ã®å°éšåã
ãªãã¶ã¬ãŒãå¡©ã«è»¢åãããïŒèç¹100â102âïŒ Vcçæç©ã¯100âã«å ç±ãã油济äžã®çææ²¹
ïŒæº¶åªäœ¿çšããïŒã«åœéã®ãžã±ãã³ãïŒæ»Žã¥ã€å
ããŠãã®å Žã§çæããã å®æœäŸ 12 ïŒâãâïŒããšãã«ã¡ãã«ïŒâNâ²âãïŒâïŒããš
ãã«ããªïŒãšãã«ãã¢ããããããã«ã¡ãã«ã¢
ã»ãã¢ã»ããŒãïŒVcïŒ ãã®äžéäœã¯å®æœäŸ11ã«èšèŒãããšåãæ¹æ³ã
çšããããåºçºç©è³ªãšããŠïŒ®âããšãã«ã¡ãã«â
Nâ²âããšãã«ããªâãšãã¬ã³ãžã¢ãã³ïŒïŒã
çšããŠãã®å Žã§çæãããç²åå¿æ²¹ãã¯ãŒã²ã«ã
ãŒã«èžçããŠäžéäœååç©ãåç58ïŒ ã§ããã
沞ç¹0.1mmã«ãããŠ170âãé©åœããVcçæç©ã¯
äžéäœæ²¹ããžã±ãã³ã§åŠçããŠãã®å Žã§çæã
ãã  å®æœäŸã®äžéäœ å®æœäŸ 13 ïŒïŒâã¯ãããããã«ïŒã¡ãã«ïŒïŒïŒâãžãã
ãâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããš
ãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬ãŒã
ïŒïœïŒ ã¢ã³ã¢ããŠã ã¢ã»ããŒã3.85gïŒ50.0ããªã¢ã«ïŒ
ãïŒâã¯ãããããã«ã¢ã»ãã¢ã»ããŒã8.15gïŒå®
æœäŸïŒã50.0ããªã¢ã«ïŒãšç¡æ°Žãšã¿ããŒã«50mlã®
溶液ã«å ãçªçŽ ã®ããšã§ïŒæééæµããã次ãã§
ïŒâããããã³ãºã¢ã«ããããšã¡ãã«ã¢ã»ãã¢ã»
ããŒã12.5gïŒ50.0ããªã¢ã«ïŒã®çž®åã§è£œé ããã¡
ãã«ïŒâãïŒïŒâãããããšãã«ïŒã¡ãã¬ã³ãâïŒ
âãªã¯ãœãã¿ããšãŒãïŒå®æœäŸïŒåç §ïŒãå ãã
ãé»è²æº¶æ¶²ãæŽã«12æééæµãããã宀枩ã«å·åŽ
ã溶åªãç空é€å»ããŠæ®æž£ããšã¿ããŒã«ããåæ¶
åºãããŠæãïœçæç©ãé»è²åºäœãšããŠããã
èç¹125â130°ã NMRïŒDMSOâd6ïŒïŒ2.04ïŒïŒïŒïœïŒïŒ2.35ïŒïŒïŒ
ïœïŒïŒ3.42ïŒïŒïŒïœïŒ6.5HzïŒïŒ3.64ïŒïŒïŒïœïŒïŒ4.20
ïŒïŒïŒïœïŒ6.3HzïŒïŒ5.07ïŒïŒïŒïœïŒïŒ7.40ïŒïŒïŒ
ïœïŒïŒ7.64ïŒïŒïŒïœïŒïŒ8.05ïŒïŒïŒïœïŒã IRïŒKBrïŒïŒ705ã1100ã1120ã1215ã1350ã
1490ã1530ã1650ã1685ã1700ã3370ã å®æœäŸ 14 ãïŒâïŒããã«ã¢ããïŒãããã«ãã¡ãã«ïŒïŒ
ïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâ
ãããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ã
ãã·ã¬ãŒãïŒïœïŒ ïœâããã«ãã«ã ã¢ãããããã«ã¢ã»ãã¢ã»ã
ãŒã23.1gïŒVb.0.10ã¢ã«ïŒã250mlã®ç¡æ°Žãšã¿ããŒ
ã«ã«æº¶æ¶²ãšãããã«ã¢ã³ã¢ããŠã ã¢ã»ããŒã7.7g
ïŒ0.10ã¢ã«ïŒãå ããããã溶液ãçªçŽ ã®ããšã§
ïŒæééæµããããã¡ãã«ïŒâãïŒïŒâãããããš
ãã«ïŒã¡ãã¬ã³ãâïŒâãªã¯ãœãã¿ããšãŒã24.9g
ïŒ0.10ã¢ã«ãïŒãå ãé»è²æ¶²ã17æééæµãã
ããåå¿æ··åç©ãç空æ¿çž®ããŠæé»è²æ¶²äœç²
57gãããããã®æ®ç液ãç¡æ°Žã¡ã¿ããŒã«500ml
äžã«ãšãããã«æ¿HCl8.3mlïŒ0.10ã¢ã«ïŒãå ãã
液ãçªçŽ ã®ããšã§éæµããã24æéåŸæ¶²ã宀枩ã«
å·ãç空æ¿çž®ãããããç©è³ªãå¡©åã¡ãã¬ã³äžã«
ãšãæœåºæ¶²ãæ°Žé žåã¢ã³ã¢ããŠã 液ãæ°Žããã³å¡©
溶液ã§æŽã€ããå¡©åã¡ãã¬ã³æœåºæ¶²ã䜵ããŠ
MgSO4ã§ä¹Ÿç¥ãéã液ãç空æ¿çž®ããŠæé»
è²æ²¹45.8gãããããã©ãã·ãŠã¯ãããã°ã©ã
ïŒã·ãªã«ïŒ5gã¡ã¿ããŒã«ïŒã¯ãããã«ã ïŒã«ãã
粟補ããŠé»è²æ²¹çæç©b16.9gïŒ38ïŒ ïŒãããã
ç¹æ§ãæ€ã¹ãããæ²¹ã®å°éããã·ã¬ãŒãå¡©ã«å€ã
ã¢ã»ããããªã«ããåçµæ¶ããŠé»è²åºäœãããã
èç¹142â146°ã åŒããã€äžéäœ åŒããã€ã¢ããååç©ã®å€ãã¯åžè²©ãããŠã
ããæ®ãã©ã¯ææ©åæé¢ä¿è ã«ãã€ãŠç¥ãããŠã
ãå ¬åŒæ¹æ³ã«ãã€ãŠè£œé ã§ãããç±³åœç¹èš±ç¬¬
4381401å·ãåç §ãããããåŒããã€å¿ èŠãªäž
éååç©ã®å€ãã¯äžèšåææ³ã«ãã€ãŠç€ºãããŠã
ãäžè¬åŒã«ãã補é ã§ããã å®æœäŸ 15 åŒããã€ååç©ã®äžè¬è£œé æ³ ç±³åœç¹èš±ç¬¬4381401å·ã®æ§ãªåŸæ¥æç®ã«ããã
ãé©åœãããªããµãŸãªãžãã³ïŒå®æœäŸ17ã18ãå
ç §ïŒã®åœã¢ã«éïŒ50â100ããªã¢ã«ïŒãã¢ããªã³å¡©
é žå¡©ããã³ïŒåã¯ïŒããªããšããŒã«ããã³æ¥è§Šé
ã®å¡©åãªããŠã ïŒåå¿é床ãå¢ãå¯æç©ãæå°ãš
ããããåå¿æ··åç©ã«å ããïŒãçªçŽ é°å²æ°ã®ã
ãšã§150â170âã«ä¿ã€ã油济äžã§å ç±æªæããã
油济枩床ã«éããåŸå解ããããã¬ã¹ãçºçã
ããïŒâ24æéåŸïŒã¬ã¹çºçåæ¢åã¯ç²åå¿æ··å
ç©ã®TLCåæã«ãã決å®ããïŒå 容ç©ã宀枩ãŸ
ã§å·ããããçªçŽ ã§ããçæååç©ïŒãžã¢ãã³
å¡©é žå¡©ååç©ïŒããšã¿ããŒã«ïŒãšãŒãã«æ··å液ã
ãåæ¶åºç²Ÿè£œãããã¢ãããšãã«ãµã«ãã¢ã€ã
ïŒïŒïŒ³ïŒã¯6.5ãšã¿ããŒã«æ§HClãšåŠçããŠã
ã®å¡©é žå¡©ã«å€ããåŸãšãã«ãšãŒãã«æ··å液ããå
æ¶åºãããã å®æœäŸ 16 âã¡ãã«âïŒâïŒããšãã«ããªïŒãããã³ã¢
ãã³å¡©é žå¡© å®æœäŸ15ã®æ¹æ³ã«ãããŠãªããµãŸãªãžãã³ã®ä»£
ãã«ãªããµãžãã³ãçšããŠãã®ååç©ã補é ã
ãã ããªããšããŒã«2.75gïŒ25.0ããªã¢ã«ïŒãããã©
ãããâïŒâã¡ãã«âïŒïŒšâïŒïŒïŒâãªããµãžã³
âïŒâãªã³2.88gïŒ25.0ããªã¢ã«ïŒãå®æœäŸ19ïŒã
ãã³æ¥è§ŠéïŒçŽïŒmgïŒã®å¡©åãªããŠã ã®æ··åç©ã
170°ã®æ²¹æµŽäžã§çªçŽ ã®ããšã§å ç±ãããçŽïŒæé
åŸé»è²æ¶²ã宀枩ãŸã§å·ãã¯ãŒã²ã«ããŒã«èžçã
ïŒæ²žç¹85°ïŒ0.3mmïŒã«ãã粟補ããŠéæ液äœçæ
ç©3.4gïŒ72ïŒ ïŒããããå°éè©Šæããšãå¡©é žå¡©ã«
å€ããšã¿ããŒã«ïŒãšãŒãã«ããåæ¶åºãããŠç¡è²
çœè²åºäœããããèç¹119â121âã å®æœäŸ 17 ïŒâïŒããšãã«ã¡ãã«ïŒâïŒâãªããµãŸãªãžãã³
ïŒR7ïŒCH2PhïŒïŒåŒååç©è£œé çšäžéäœïŒ 也ç¥THF100mläžã«æ°ŽçŽ åãããªãŠã ïŒ0.55ã¢
ã«ããããµã³æŽæµããïŒå·ïŒæ°·æµŽïŒæžæ¿æ¶²ãçªçŽ
é°å²æ°ã®ããšã§æªæããªãã10ïŒ1THFïŒ
DMF500mlã滎å ãããããç°è²æžæ¿æ¶²ã宀枩ã«
ãããã24æéæªæããããçœè²æžæ¿æ¶²ã«ãã³ãž
ã«ãããã€ã66mlïŒ0.056ã¢ã«ïŒãå ã宀枩ã§24
æéæªæãããåå¿æ··åç©ã«æ³šæããŠ26mlã®æ°Žã
å ããæ··åç©ãæ¿çž®ã500mlã®æ°Žäžã«æ³šå ¥ããã
å¡©åã¡ãã¬ã³ã§æœåºãæœåºæ¶²ã䜵ãæ°Žãšå¡©æº¶æ¶²ã§
æŽãMgSO4äžã§ä¹Ÿç¥ãç空æ¿çž®ããŠé»è²æ²¹104g
ãããããããã¯ãŒã²ã«ããŒã«èžçïŒæ²žç¹100°ïŒ
0.1mmïŒã§ç²Ÿè£œãç¡è²æ¶²äœçæç©81gïŒåç92ïŒ ïŒ
ããããããã宀枩ã§æŸçœ®ãããšç¡è²åºäœãšãªã€
ããèç¹76â78âã å®æœäŸ 18 ïŒâãïŒâïŒããšãã«ããªïŒãšãã«ãâïŒâãªã
ãµãŸãªãžãã³ïŒR7ïŒCH2CH2SPhïŒ å®æœäŸ17ãšåæ§ã®æ¹æ³ãå埩ãããããã³ãžã«
ãããã€ãã®ä»£ãã«ããã¢ãšãã«ããšãã«ãµã«ã
ã¢ã€ããçšãããã¯ãããã°ã©ãïŒã·ãªã«ïŒ
CHCl3ïŒã«ããé»è²æ²¹çæç©ãªããµãŸãªãžãã³
ïŒ17ïŒ ïŒãããã å®æœäŸ 19 ããã©ãããâïŒâã¡ãã«â2HâïŒïŒïŒâãª
ããµãžã³âïŒâãªã³ïŒR7ïŒCH3ïŒ ä¹Ÿç¥THF50mläžã«ãããµã³æŽæµåŸã®æ°ŽçŽ åã
ããªãŠã ïŒ0.10ã¢ã«ïŒã®æžæ¿æ¶²ãçªçŽ ã®ããšã§æª
æããªããTHF50mläžã«ããã©ãããâïŒïŒšâ
ïŒïŒïŒâãªããµãžã³âïŒâãªã³8.20gïŒ0.0812ã¢
ã«ïŒã®æº¶æ¶²ããã¥ãã«å ãããããæžæ¿æ¶²ã宀枩
ã§ïŒæéæªæåŸããåã¡ãã«28gïŒ0.02ã¢ã«ïŒãå
ãæ··åç©ãäžå€æªæãããåå¿æ··åç©ã«æ°ŽïŒmlã
å ã液ã塩溶液500mlã«æ³šå ¥ããã液ãé£ç¶ïŒæ¥
éå¡©åã¡ãã¬ã³ã§æœåºãææ©éšåãæ¿çž®ããŠç²ç
æç©7.8gããããã¯ãŒã²ã«ããŒã«èžçïŒæ²žç¹
101°ïŒ0.4mmïŒã«ãã粟補ããŠéæ液äœçæç©6.7g
ïŒ72ïŒ ïŒãããããã®äžéäœãå¿çšãäžèšæ¹æ³ã«
ãã€ãŠè£œé ããåŒããã€äžéã®è¿œå äŸãè¡šïŒã«
瀺ãã
ãè¡šã
ãè¡šã
çæç©ã®åæ
äžèšã¯åå¿å·¥çšå³ïŒã®åææ³ïŒïœïŒãçšããåŒ
ããã€çæç©ã®äžè¬è£œæ³ã§ããã å®æœäŸ 30 åŒããã€ååç©åæç©ïŒïœïŒã®äžè¬æ³ ã¢ã»ããããªã«35â50mläžã®ã¯ãããããã«ãž
ãããããªãžã³4.09gïŒ10.0ããªã¢ã«ãïœïŒãåŒ
äžéäœã¢ããååç©ïŒ20â30ããªã¢ã«ïŒãããª
ãšãã«ã¢ãã³2.1gïŒ20ããªã¢ã«ïŒããã³ããåã
ããªãŠã 10â20mgã®æº¶æ¶²ããçªçŽ ã®ããšã§æ°æ¥é
åã¯TLCåæãïœäžååšã瀺ããŸã§éæµããã
液ãç空æ¿çž®ãæ®æž£ãå¡©åã¡ãã¬ã³äžã«ãšãæ°Žã
10ïŒ HCl氎溶液ïŒïŒ¶ïŒïŒ¶ïŒãæ°ŽãïŒïŒ HaOH氎溶
液ïŒïŒ·ïŒïŒ¶ïŒæ°Žããã³å¡©æº¶æ¶²ã§é 次æŽã€ãã液ã
çé žã«ãªãŠã äžã§ä¹Ÿããéãç空æ¿çž®ããŠç²é»
è²æ²¹ããããæ²¹ç¶çæç©ããã©ãã·ãŠã¯ããã
ã°ã©ãïŒã·ãªã«ïŒã¡ã¿ããŒã«ïŒã¯ãããã«ã 溶é¢
液ïŒã§ç²Ÿè£œããåŸãã®å¡©é žå¡©ã«å€ãããæ®ãã©ã®
å Žåãã®çæç©ã¯ç¡å®åœ¢é»è²åºäœã§ã¯ã€ãããã
èç¹ã瀺ããªãã€ããååç©ã®ååãªåæçµæã
ãããããïŒïŒ£ããã«ã€ã±0.4ïŒ ãäžèšè¡šïŒ
åç §ïŒãŸããã®ç€ºãããæ§é ãšäžèŽããã¹ãã¯ã
ã«ç¹æ§ïŒIRãMSããããã³âNMRïŒã瀺ããã å®æœäŸ 31 ã¡ãã«ãïŒâãâã¡ãã«ââïŒïŒâïŒããšã
ã«ããªïŒãšãã«ãâã¢ããããããã«ãïŒïŒïŒ
âãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒïŒïŒïŒâããªãžã³ãžã«ã«ããã·
ã¬ãŒãå¡©é žå¡© 也ç¥ã¢ã»ããããªã«50mläžã®ãžãããããªãžã³
a4.08gïŒ10.0ããªã¢ã«ãå®æœäŸ13ïŒãã¢ãããµã«
ãã¢ã€ã3.10gïŒ20.0ããªã¢ã«ãå®æœäŸ25ïŒãã
ãªãšãã«ã¢ãã³2.1gïŒ20ããªã¢ã«ïŒããã³æ¥è§Šé
ã®ããåãããªãŠã ã®æº¶æ¶²ãïŒæ¥ééæµãããã
æ··åç©ãç空æ¿çž®ãæ®æž£ãå¡©åã¡ãã¬ã³100mlã«
ãšã€ãããããïŒïŒ HCl氎溶液ãæ°ŽãïŒïŒ NaOH
氎溶液ãæ°Žããã³å¡©æº¶æ¶²ã§æŽã€ãåŸçé žã«ãªãŠã
äžã§ä¹Ÿããéãããæ®çºåãç空é€å»ããŠé»è²
æ²¹ç²çæç©5.4gãããããã©ãã·ãŠã¯ãããã°ã©
ãïŒã·ãªã«ïŒCHCl3ïŒåŸ2.5ïŒ ãšïŒïŒ ã¡ã¿ããŒ
ã«ïŒCHCl3溶é¢æ¶²ïŒã§ç²Ÿè£œããŠé»è²æ²¹çæç©2.9
ïŒ ïŒåç54ïŒ ïŒãããã6.5ãšã¿ããŒã«æ§HCl
ã§åŠçããŠå¡©é žå¡©ã«å€ãããçæç©ããšã¿ããŒã«
ããåæ¶åºãããŠé»è²åºäœããããèç¹137â140
âã ãã®æ¹æ³ã§è£œé ããçæç©ã®ä»£è¡šçäŸãè¡šïŒ
ã«ç€ºããŠããã
ããã€çæç©ã®äžè¬è£œæ³ã§ããã å®æœäŸ 30 åŒããã€ååç©åæç©ïŒïœïŒã®äžè¬æ³ ã¢ã»ããããªã«35â50mläžã®ã¯ãããããã«ãž
ãããããªãžã³4.09gïŒ10.0ããªã¢ã«ãïœïŒãåŒ
äžéäœã¢ããååç©ïŒ20â30ããªã¢ã«ïŒãããª
ãšãã«ã¢ãã³2.1gïŒ20ããªã¢ã«ïŒããã³ããåã
ããªãŠã 10â20mgã®æº¶æ¶²ããçªçŽ ã®ããšã§æ°æ¥é
åã¯TLCåæãïœäžååšã瀺ããŸã§éæµããã
液ãç空æ¿çž®ãæ®æž£ãå¡©åã¡ãã¬ã³äžã«ãšãæ°Žã
10ïŒ HCl氎溶液ïŒïŒ¶ïŒïŒ¶ïŒãæ°ŽãïŒïŒ HaOH氎溶
液ïŒïŒ·ïŒïŒ¶ïŒæ°Žããã³å¡©æº¶æ¶²ã§é 次æŽã€ãã液ã
çé žã«ãªãŠã äžã§ä¹Ÿããéãç空æ¿çž®ããŠç²é»
è²æ²¹ããããæ²¹ç¶çæç©ããã©ãã·ãŠã¯ããã
ã°ã©ãïŒã·ãªã«ïŒã¡ã¿ããŒã«ïŒã¯ãããã«ã 溶é¢
液ïŒã§ç²Ÿè£œããåŸãã®å¡©é žå¡©ã«å€ãããæ®ãã©ã®
å Žåãã®çæç©ã¯ç¡å®åœ¢é»è²åºäœã§ã¯ã€ãããã
èç¹ã瀺ããªãã€ããååç©ã®ååãªåæçµæã
ãããããïŒïŒ£ããã«ã€ã±0.4ïŒ ãäžèšè¡šïŒ
åç §ïŒãŸããã®ç€ºãããæ§é ãšäžèŽããã¹ãã¯ã
ã«ç¹æ§ïŒIRãMSããããã³âNMRïŒã瀺ããã å®æœäŸ 31 ã¡ãã«ãïŒâãâã¡ãã«ââïŒïŒâïŒããšã
ã«ããªïŒãšãã«ãâã¢ããããããã«ãïŒïŒïŒ
âãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒïŒïŒïŒâããªãžã³ãžã«ã«ããã·
ã¬ãŒãå¡©é žå¡© 也ç¥ã¢ã»ããããªã«50mläžã®ãžãããããªãžã³
a4.08gïŒ10.0ããªã¢ã«ãå®æœäŸ13ïŒãã¢ãããµã«
ãã¢ã€ã3.10gïŒ20.0ããªã¢ã«ãå®æœäŸ25ïŒãã
ãªãšãã«ã¢ãã³2.1gïŒ20ããªã¢ã«ïŒããã³æ¥è§Šé
ã®ããåãããªãŠã ã®æº¶æ¶²ãïŒæ¥ééæµãããã
æ··åç©ãç空æ¿çž®ãæ®æž£ãå¡©åã¡ãã¬ã³100mlã«
ãšã€ãããããïŒïŒ HCl氎溶液ãæ°ŽãïŒïŒ NaOH
氎溶液ãæ°Žããã³å¡©æº¶æ¶²ã§æŽã€ãåŸçé žã«ãªãŠã
äžã§ä¹Ÿããéãããæ®çºåãç空é€å»ããŠé»è²
æ²¹ç²çæç©5.4gãããããã©ãã·ãŠã¯ãããã°ã©
ãïŒã·ãªã«ïŒCHCl3ïŒåŸ2.5ïŒ ãšïŒïŒ ã¡ã¿ããŒ
ã«ïŒCHCl3溶é¢æ¶²ïŒã§ç²Ÿè£œããŠé»è²æ²¹çæç©2.9
ïŒ ïŒåç54ïŒ ïŒãããã6.5ãšã¿ããŒã«æ§HCl
ã§åŠçããŠå¡©é žå¡©ã«å€ãããçæç©ããšã¿ããŒã«
ããåæ¶åºãããŠé»è²åºäœããããèç¹137â140
âã ãã®æ¹æ³ã§è£œé ããçæç©ã®ä»£è¡šçäŸãè¡šïŒ
ã«ç€ºããŠããã
ãè¡šã
ãè¡šã
次ã®å®æœäŸã¯åå¿å·¥çšå³ïŒã®åææ³ïŒïœïŒãçš
ããåŒããã€çæç©ã®äžè¬è£œé æ³ã瀺ããã®ã§
ããã å®æœäŸ 44 ãïŒâããâããã«ââïŒïŒâããšããã·ãš
ãã«ïŒãã¢ããããããã«ãã¡ãã«ïŒïŒïŒâãž
ãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâããã
ããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬
ãŒãå¡©é žå¡©åæ°Žåç© ãïŒâïŒããã«ã¢ããïŒãããã«ãã¡ãã«ïŒïŒ
ïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·
ã¬ãŒã4.26gïŒ9.57ããªã¢ã«ãïœïŒãβâããã¢
ããšãããŒã«2.01gïŒ10ããªã¢ã«ïŒãããªãšãã«ã¢
ãã³10ããªã¢ã«ããã³ã¢ã»ããããªã«50mlã®æ··å
溶液ãçªçŽ ã®ããšã§24æééæµããããæ··åç©ã
ç空æ¿çž®ãå¡©åã¡ãã¬ã³äžã«ãšãæ°Žãšå¡©æº¶æ¶²ã§æŽ
ã€ããçé žã«ãªãŠã äžã§ä¹ŸãããåŸå¡©åã¡ãã¬ã³
液ãéã液ãç空æ¿çž®ããŠæé»è²æ¶²äœãšããŠ
ç²çæç©6.1gããããããããã©ãã·ãŠã¯ããã
ã°ã©ãïŒã·ãªã«ïŒïŒïŒ ã¡ã¿ããŒã«ïŒã¯ãããã«
ã ïŒã§ç²Ÿè£œãå¡©åºåœ¢çæç©é»è²æ²¹3.0gïŒ57ïŒ ïŒã
ãããããã6.5ãšã¿ããŒã«æ§HClãšåŠçããŠ
å¡©é žå¡©ãšãé»è²ããªãŒã ãšããŠåé¢ããã ïŒèç¹äžæçïŒ æ¬¡ã®å®æœäŸã¯åå¿å·¥çšå³ïŒã®åææ³ïŒïœïŒã䜿
ãåŒããã€ååç©ã®äžè¬è£œé æ³ã瀺ããã®ã§ã
ãã å®æœäŸ 45 ãïŒâããïŒâïŒïŒ®âã¡ãã«ââããšãã«ïŒã¢
ããããšãã«ãâNâ²âããšãã«ã¡ãã«ãããã
ã«ãã¡ãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ã
ã«âïŒâïŒïŒâãããããšãã«ïŒïŒïŒïŒâããª
ãžã³âãžã«ã«ããã·ã¬ãŒãïŒå¡©é žå¡©ã»ã¹ãæ°Žå
ç© å®æœäŸ11ã«èšèŒã®ãšããäžéäœ4.47gïŒ150ããª
ã¢ã«ïŒã100â油济äžã§ç±ããªãããžã±ãã³1.25g
ïŒ15.0ããªã¢ã«ïŒã滎å ããŠãã®å Žã§ïŒâããïŒâ
ãïŒïŒ®âã¡ãã«ââããšãã«ïŒã¢ããããšãã«ã
âNâ²âããšãã«ã¡ãã«ïŒã¢ããããããã«ãã¡
ãã«ã¢ã»ãã¢ã»ããŒãïŒVcïŒãçæãããæ·»å
å®äºåŸãšã¿ããŒã«50mlãšé ¢é žã¢ã³ã¢ããŠã 1.15g
ïŒ14.9ããªã¢ã«ïŒãå ãããã溶液ãïŒæééæµ
ããããã¡ãã«ïŒâããïŒâãããããšãã«ïŒã¡ã
ã¬ã³ãâïŒâãªã¯ãœãã¿ããšãŒã3.7gïŒ14.9ããªã¢
ã«ãïŒãå ããŠæŽã«18æééæµããããåå¿æ··
åç©ãç空æ¿çž®ãæ®æž£ããã©ãã·ãŠã¯ãããã°ã©
ãïŒã·ãªã«ïŒã¡ã¿ããŒã«ïŒã¯ãããã«ã 溶液ïŒã§
粟補ããŠçæç©é»è²æ²¹2.3gïŒ25ïŒ ïŒããããã
ã®ç©è³ªããšã¿ããŒã«æ§HClãšåŠçããŠïŒå¡©é žå¡©ã«
å€ãé»è²ããªãŒã ããããèç¹75â85âã 1HNMRïŒDMSOâd6ïŒïŒÎŽ2.36ïŒïœïŒïŒïŒïŒ2.28
ïŒïœïŒïŒïŒã2.91ïŒïœïŒïŒïŒã3.20ïŒïœïŒïŒïŒã3.60
ïŒïœïŒïŒïŒã4.00ïŒïœïŒïŒïŒã4.42ïŒïœïŒïŒïŒã5.00
ïŒïœïŒïŒïŒã6.78ïŒïœïŒïŒïŒã7.20ïŒïœïŒïŒïŒã7.50
ïŒïœïŒïŒïŒã8.02ïŒïœïŒïŒïŒã9.30ïŒbsïŒïŒïŒã11.60
ïŒbsïŒïŒïŒã IRïŒKBrïŒïŒ3100ã2600ã1695ã1530ã1490ã
1350ã1215ã1120ã1100ã750ããã³750cm-1ã å®æœäŸ 46 ã¡ãã«ãïŒâãâïŒããšãã«ã¡ãã«ïŒââãïŒ
âïŒããšãã«ããªïŒâãšãã«ãã¢ãããããã
ã«ãïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒâïŒïŒïŒâããªãžã³ãž
ã«ã«ããã·ã¬ãŒãå¡©é žå¡© äžèšå®æœäŸ45ãšåãæ¹æ³ãçšããŠïŒâãâïŒã
ãšãã«ã¡ãã«ïŒâNâ²âãïŒâïŒããšãã«ããªïŒãšã
ã«ãã¢ããããããã«ãã¡ãã«ã¢ã»ãã¢ã»ããŒã
ïŒVcïŒããåºçºããŠå¯Ÿå¿ããåŒããã€çæç©ã
åç60ïŒ ã§è£œé ãããçæç©ãé»è²ç¡å®åœ¢å¡©é žå¡©
ã®åœ¢ã§åé¢ããããã®èç¹ã¯äžæçã§ãã€ãã 次ã®å®æœäŸã¯åå¿å·¥çšå³ïŒã®åææ³ïŒïœïŒãçš
ããåŒããã€çæç©ã®äžè¬è£œé æ³ã瀺ããã®ã§
ããã å®æœäŸ 47 ã¡ãã«ãïŒâãâã¡ãã«ââãïŒâããšãã«
ã¹ã«ãã€ãã«ïŒãšãã«ãâã¢ããããããã«ã
ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâ
ïŒïŒâãããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«
ã«ããã·ã¬ãŒãå¡©é žå¡©æ°Žåç© ã¬ãªããŒããšãžãšã³ãœã³ã®J.Org.Chem.27ïŒ
282ïŒ1961ïŒã«èšèŒã®äžè¬é žåæ³ã«ãã€ãŠã¡ã¿ããŒ
ã«50mläžã®ã¡ãã«ãïŒâãâã¡ãã«ââãïŒâ
ããšãã«ããªïŒãšãã«ãã¢ããããããã«ãïŒïŒ
ïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬
ãŒã2.32gïŒ3.99ããªã¢ã«ãå®æœäŸ34ïŒã®æº¶æ¶²ãæ°Ž
50mläžã®éããçŽ é žãããªãŠã 0.96gïŒ4.4ããªã¢
ã«ïŒã®æº¶æ¶²ã§åŠçãããã液ã宀枩ã§18æéæªæ
ããåŸæ°Žãå ãããå¡©åã¡ãã¬ã³ã§æœåºã䜵ãã
ææ©éšåãç¡«é žãããªãŠã äžã§ä¹Ÿããéãç空
æ¿çž®ããŠé»è²ããªãŒã 1.8gããããããããã©ã
ã·ãŠã¯ãããã°ã©ãïŒã·ãªã«ïŒã¡ã¿ããŒã«ïŒã¯ã
ããã«ã ïŒç²Ÿè£œããŠïŒžããºã«ããªãã·ãã§ãã
çæç©1.24gïŒ50ïŒ ïŒãé»è²æ²¹ãšããŠãããéé¢å¡©
åºæ§æ²¹ãå¡©é žå¡©ã«å€ããŠé»è²ããªãŒã ããããè
ç¹80â95°ã äžèšã®ãšããåŒçæç©ã¯æ®ãã©äžè¬ã«ç²ãæ²¹
ã§å¡©é žå¡©ãšããç¡å®åœ¢é»è²åºäœã«ãªããæ®ãã©ã
ã®å Žåãã®å¡©é žå¡©ã¯ã¯ã€ããããèç¹ã瀺ããªã
ãããããã¯ååãªåæçµæãäžããããããã®
äŸã¯äžè¡šïŒã«ç€ºããŠããã
ããåŒããã€çæç©ã®äžè¬è£œé æ³ã瀺ããã®ã§
ããã å®æœäŸ 44 ãïŒâããâããã«ââïŒïŒâããšããã·ãš
ãã«ïŒãã¢ããããããã«ãã¡ãã«ïŒïŒïŒâãž
ãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâããã
ããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬
ãŒãå¡©é žå¡©åæ°Žåç© ãïŒâïŒããã«ã¢ããïŒãããã«ãã¡ãã«ïŒïŒ
ïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·
ã¬ãŒã4.26gïŒ9.57ããªã¢ã«ãïœïŒãβâããã¢
ããšãããŒã«2.01gïŒ10ããªã¢ã«ïŒãããªãšãã«ã¢
ãã³10ããªã¢ã«ããã³ã¢ã»ããããªã«50mlã®æ··å
溶液ãçªçŽ ã®ããšã§24æééæµããããæ··åç©ã
ç空æ¿çž®ãå¡©åã¡ãã¬ã³äžã«ãšãæ°Žãšå¡©æº¶æ¶²ã§æŽ
ã€ããçé žã«ãªãŠã äžã§ä¹ŸãããåŸå¡©åã¡ãã¬ã³
液ãéã液ãç空æ¿çž®ããŠæé»è²æ¶²äœãšããŠ
ç²çæç©6.1gããããããããã©ãã·ãŠã¯ããã
ã°ã©ãïŒã·ãªã«ïŒïŒïŒ ã¡ã¿ããŒã«ïŒã¯ãããã«
ã ïŒã§ç²Ÿè£œãå¡©åºåœ¢çæç©é»è²æ²¹3.0gïŒ57ïŒ ïŒã
ãããããã6.5ãšã¿ããŒã«æ§HClãšåŠçããŠ
å¡©é žå¡©ãšãé»è²ããªãŒã ãšããŠåé¢ããã ïŒèç¹äžæçïŒ æ¬¡ã®å®æœäŸã¯åå¿å·¥çšå³ïŒã®åææ³ïŒïœïŒã䜿
ãåŒããã€ååç©ã®äžè¬è£œé æ³ã瀺ããã®ã§ã
ãã å®æœäŸ 45 ãïŒâããïŒâïŒïŒ®âã¡ãã«ââããšãã«ïŒã¢
ããããšãã«ãâNâ²âããšãã«ã¡ãã«ãããã
ã«ãã¡ãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ã
ã«âïŒâïŒïŒâãããããšãã«ïŒïŒïŒïŒâããª
ãžã³âãžã«ã«ããã·ã¬ãŒãïŒå¡©é žå¡©ã»ã¹ãæ°Žå
ç© å®æœäŸ11ã«èšèŒã®ãšããäžéäœ4.47gïŒ150ããª
ã¢ã«ïŒã100â油济äžã§ç±ããªãããžã±ãã³1.25g
ïŒ15.0ããªã¢ã«ïŒã滎å ããŠãã®å Žã§ïŒâããïŒâ
ãïŒïŒ®âã¡ãã«ââããšãã«ïŒã¢ããããšãã«ã
âNâ²âããšãã«ã¡ãã«ïŒã¢ããããããã«ãã¡
ãã«ã¢ã»ãã¢ã»ããŒãïŒVcïŒãçæãããæ·»å
å®äºåŸãšã¿ããŒã«50mlãšé ¢é žã¢ã³ã¢ããŠã 1.15g
ïŒ14.9ããªã¢ã«ïŒãå ãããã溶液ãïŒæééæµ
ããããã¡ãã«ïŒâããïŒâãããããšãã«ïŒã¡ã
ã¬ã³ãâïŒâãªã¯ãœãã¿ããšãŒã3.7gïŒ14.9ããªã¢
ã«ãïŒãå ããŠæŽã«18æééæµããããåå¿æ··
åç©ãç空æ¿çž®ãæ®æž£ããã©ãã·ãŠã¯ãããã°ã©
ãïŒã·ãªã«ïŒã¡ã¿ããŒã«ïŒã¯ãããã«ã 溶液ïŒã§
粟補ããŠçæç©é»è²æ²¹2.3gïŒ25ïŒ ïŒããããã
ã®ç©è³ªããšã¿ããŒã«æ§HClãšåŠçããŠïŒå¡©é žå¡©ã«
å€ãé»è²ããªãŒã ããããèç¹75â85âã 1HNMRïŒDMSOâd6ïŒïŒÎŽ2.36ïŒïœïŒïŒïŒïŒ2.28
ïŒïœïŒïŒïŒã2.91ïŒïœïŒïŒïŒã3.20ïŒïœïŒïŒïŒã3.60
ïŒïœïŒïŒïŒã4.00ïŒïœïŒïŒïŒã4.42ïŒïœïŒïŒïŒã5.00
ïŒïœïŒïŒïŒã6.78ïŒïœïŒïŒïŒã7.20ïŒïœïŒïŒïŒã7.50
ïŒïœïŒïŒïŒã8.02ïŒïœïŒïŒïŒã9.30ïŒbsïŒïŒïŒã11.60
ïŒbsïŒïŒïŒã IRïŒKBrïŒïŒ3100ã2600ã1695ã1530ã1490ã
1350ã1215ã1120ã1100ã750ããã³750cm-1ã å®æœäŸ 46 ã¡ãã«ãïŒâãâïŒããšãã«ã¡ãã«ïŒââãïŒ
âïŒããšãã«ããªïŒâãšãã«ãã¢ãããããã
ã«ãïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒâïŒïŒïŒâããªãžã³ãž
ã«ã«ããã·ã¬ãŒãå¡©é žå¡© äžèšå®æœäŸ45ãšåãæ¹æ³ãçšããŠïŒâãâïŒã
ãšãã«ã¡ãã«ïŒâNâ²âãïŒâïŒããšãã«ããªïŒãšã
ã«ãã¢ããããããã«ãã¡ãã«ã¢ã»ãã¢ã»ããŒã
ïŒVcïŒããåºçºããŠå¯Ÿå¿ããåŒããã€çæç©ã
åç60ïŒ ã§è£œé ãããçæç©ãé»è²ç¡å®åœ¢å¡©é žå¡©
ã®åœ¢ã§åé¢ããããã®èç¹ã¯äžæçã§ãã€ãã 次ã®å®æœäŸã¯åå¿å·¥çšå³ïŒã®åææ³ïŒïœïŒãçš
ããåŒããã€çæç©ã®äžè¬è£œé æ³ã瀺ããã®ã§
ããã å®æœäŸ 47 ã¡ãã«ãïŒâãâã¡ãã«ââãïŒâããšãã«
ã¹ã«ãã€ãã«ïŒãšãã«ãâã¢ããããããã«ã
ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâ
ïŒïŒâãããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«
ã«ããã·ã¬ãŒãå¡©é žå¡©æ°Žåç© ã¬ãªããŒããšãžãšã³ãœã³ã®J.Org.Chem.27ïŒ
282ïŒ1961ïŒã«èšèŒã®äžè¬é žåæ³ã«ãã€ãŠã¡ã¿ããŒ
ã«50mläžã®ã¡ãã«ãïŒâãâã¡ãã«ââãïŒâ
ããšãã«ããªïŒãšãã«ãã¢ããããããã«ãïŒïŒ
ïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬
ãŒã2.32gïŒ3.99ããªã¢ã«ãå®æœäŸ34ïŒã®æº¶æ¶²ãæ°Ž
50mläžã®éããçŽ é žãããªãŠã 0.96gïŒ4.4ããªã¢
ã«ïŒã®æº¶æ¶²ã§åŠçãããã液ã宀枩ã§18æéæªæ
ããåŸæ°Žãå ãããå¡©åã¡ãã¬ã³ã§æœåºã䜵ãã
ææ©éšåãç¡«é žãããªãŠã äžã§ä¹Ÿããéãç空
æ¿çž®ããŠé»è²ããªãŒã 1.8gããããããããã©ã
ã·ãŠã¯ãããã°ã©ãïŒã·ãªã«ïŒã¡ã¿ããŒã«ïŒã¯ã
ããã«ã ïŒç²Ÿè£œããŠïŒžããºã«ããªãã·ãã§ãã
çæç©1.24gïŒ50ïŒ ïŒãé»è²æ²¹ãšããŠãããéé¢å¡©
åºæ§æ²¹ãå¡©é žå¡©ã«å€ããŠé»è²ããªãŒã ããããè
ç¹80â95°ã äžèšã®ãšããåŒçæç©ã¯æ®ãã©äžè¬ã«ç²ãæ²¹
ã§å¡©é žå¡©ãšããç¡å®åœ¢é»è²åºäœã«ãªããæ®ãã©ã
ã®å Žåãã®å¡©é žå¡©ã¯ã¯ã€ããããèç¹ã瀺ããªã
ãããããã¯ååãªåæçµæãäžããããããã®
äŸã¯äžè¡šïŒã«ç€ºããŠããã
ãè¡šã
åŒããã€ååç©ã®çç©åŠç掻æ§
æ¬ã·ãªãŒãºã®åŒååç©ã®ããé©åãªçç©åŠç
掻æ§ã¯ã«ã«ã·ãŠã æå¶ãæâé»è¡æ§æŽ»æ§ããã³å°
æ¿åéæå¶æ§ã§ããããã®æŽ»æ§ãããããçç©åŠ
çè©ŠéšããŒã¿ã¯è¡šïŒã«æ¬ã·ãªãŒãºã®ãããã åå
ç©äŸã«ã€ããŠç€ºããŠããã
掻æ§ã¯ã«ã«ã·ãŠã æå¶ãæâé»è¡æ§æŽ»æ§ããã³å°
æ¿åéæå¶æ§ã§ããããã®æŽ»æ§ãããããçç©åŠ
çè©ŠéšããŒã¿ã¯è¡šïŒã«æ¬ã·ãªãŒãºã®ãããã åå
ç©äŸã«ã€ããŠç€ºããŠããã
ãè¡šã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒïŒ ïŒäžåŒäžR2ãR5ãR6ã¯åç¡é¢ä¿ã«äœçŽïŒC1â
C4ïŒã¢ã«ãã«ãããããã·äœçŽã¢ã¬ãã¬ã³ãäœ
çŽã¢ã«ã³ãã·âäœçŽã¢ã«ãã¬ã³ãäœçŽã¢ã«ãã«ã¢
ããâäœçŽã¢ã«ãã¬ã³åã¯äœçŽãžã¢ã«ãã«ã¢ãã
âäœçŽã¢ã«ãã¬ã³ããããã°ããåºãããããã
R7ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«âäœçŽã¢ã«
ãã¬ã³åã¯ããšãã«ããªâäœçŽã¢ã«ãã¬ã³ããã
ãã°ããåºããããããïœã¯ïŒåã¯ïŒã®æŽæ°ãš
ããã¯ååŠçµåãââãââããåŒãå ã¯NR9ããããããäœãR9ã¯æ°ŽçŽ ãäœçŽã¢ã«ã
ã«ãããšãã«ãåã¯ããšãã«âäœçŽã¢ã«ãã¬ã³ã
ãããããäœããååŠçµåã§ãããšãã¯ïŒºã¯ïŒ
âã€ã³ããªã«ç°ãããããããã€ïŒºã¯æ°ŽçŽ ãäœçŽ
ã¢ã«ãã«åã¯äœçŽã¢ã«ã³ãã·ããç¡é¢ä¿ã«ããã°
ããïŒä¹è³ïŒã®çœ®æåºã§çœ®æãããããšãã«ãã
ãšãã«âäœçŽã¢ã«ãã¬ã³åã¯ïŒâã€ã³ããªã«ãã
æã矀ããããã°ããåºããããããïŒã§ç€ºãã
ãããšãç¹åŸŽãšããååç©ããã³ãã®è£œè¬äžèš±å®¹
ãããé žä»å å¡©ã ïŒ R2ãR5ãR6ããšãã«äœçŽã¢ã«ãã«ã§ããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ R7ãäœçŽã¢ã«ãã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé ã«èšèŒã®ååç©ã ïŒ ïŒžãââåã¯âNR9ã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ ïŒºãããšãã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«
èšèŒã®ååç©ã ïŒ ã¡ãã«ãïŒâããïŒââããšãã«ã¢ããïŒãš
ãã«ãã¢ããããããã«ãïŒïŒïŒâãžãããâ
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬ãŒãã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ãïŒâããïŒâïŒïŒïŒšâã€ã³ããŒã«âïŒâã€ã«ïŒ
ãšãã«ãã¢ããããããã«ãã¡ãã«ïŒïŒïŒâãžã
ããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããš
ãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬ãŒãã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ã¡ãã«ãïŒâãâã¡ãã«ââãïŒâïŒããš
ãã«ããªãšãã«ïŒã¢ããããããã«ãïŒïŒïŒâãž
ãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããã
ãšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬ãŒã
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ ã¡ãã«ãïŒâãâïŒïŒâããšããã·ãšãã«ïŒ
ã¢ããããããã«ãïŒïŒïŒâãžãããâïŒïŒïŒâ
ãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâ
ããªãžã³ãžã«ã«ããã·ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒïŒ ã¡ãã«ãïŒâãâãïŒâïŒNâ²âã¡ãã«â
Nâ²âããšãã«ã¢ããïŒãšãã«ãâNâ²âã¡ãã«ã¢ã
ãããããã«ãïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡
ãã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâããª
ãžã³ãžã«ã«ããã·ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé ã«èšèŒã®ååç©ã ïŒïŒ ã¡ãã«ãïŒâãâãïŒâïŒããšãã«ã¢ããïŒ
ãšãã«ãââã¡ãã«ã¢ããããããã«ãïŒïŒïŒ
âãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãã
ãããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬
ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®åå
ç©ã ïŒïŒ ã¡ãã«ãïŒâãâãïŒâãNâ²âããšãã«â
Nâ²âïŒããšãã«ã¡ãã«ïŒã¢ããããšãã«ãââ
ã¡ãã«ã¢ããããããã«ãïŒïŒïŒâãžãããâ
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬ãŒãã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒïŒ ã¡ãã«ãïŒâãâã¡ãã«ââãïŒâããïŒ
âã¡ãã«âïŒâïŒïŒïŒïŒâãžã¡ãã«ãšãã«ïŒããš
ãã«ãããªããšãã«ãã¢ããããããã«ãïŒïŒïŒ
âãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãã
ãããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬
ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®åå
ç©ã ïŒïŒ ã¡ãã«ãïŒâãâã¡ãã«ââãïŒâïŒã
ãšãã«ããªïŒãããã«ãã¢ããããããã«ãïŒïŒ
ïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâã
ããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·
ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®åå
ç©ã ïŒïŒ ãïŒâãâãïŒâãïŒïŒâã¡ããã·ããšã
ã«ïŒããªããšãã«ãââã¡ãã«ã¢ãããããã
ã«ãã¡ãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«
âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâããªãžã³
ãžã«ã«ããã·ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«èšèŒã®ååç©ã ïŒïŒ ã¡ãã«ãïŒâãâãïŒâïŒããšãã«ããªïŒ
ãšãã«ãã¢ããããããã«ãïŒïŒïŒâãžãããâ
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬ãŒãã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒïŒ ã¡ãã«ãïŒâãïŒïŒ®âãã¹âãïŒâïŒããš
ãã«ããªïŒãšãã«ãã¢ããããããã«ãïŒïŒïŒâ
ãžãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâããã
ããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬ãŒ
ãå¡©é žå¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®å
åç©ã ïŒïŒ ãïŒâããâããã«ââïŒïŒâããšãã
ã·ãšãã«ïŒã¢ããããããã«ãã¡ãã«ïŒïŒïŒâãž
ãããâïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããã
ãšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«ããã·ã¬ãŒã
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒïŒ ãïŒâããïŒâïŒã¡ãã«ããšãã«ã¢ããïŒãš
ãã«ãïŒããšãã«ã¡ãã«ïŒã¢ããããããã«ãã¡
ãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâ
ïŒïŒâãããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«
ããã·ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒ
ã®ååç©ã ïŒïŒ ã¡ãã«ãïŒâãâïŒããšãã«ã¡ãã«ïŒâ
âãïŒâïŒããšãã«ããªïŒãšãã«ãã¢ãããããã
ã«ãïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâ
ïŒïŒâãããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«
ããã·ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒ
ã®ååç©ã ïŒïŒ ã¡ãã«ãïŒâãâã¡ãã«ââãïŒâïŒã
ãšãã«ã¹ã«ãã€ãã«ïŒãšãã«ãã¢ãããããã
ã«ãïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒâ
ïŒïŒâãããããšãã«ïŒâïŒïŒïŒâããªãžã³ãžã«ã«
ããã·ã¬ãŒãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒ
ã®ååç©ã ïŒïŒ åŒïŒ ïŒäžåŒäžR2ãR5ãR6ã¯åç¡é¢ä¿ã«äœçŽïŒC1â
C4ïŒã¢ã«ãã«ãããããã·äœçŽã¢ã«ãã¬ã³ãäœ
çŽã¢ã«ã³ãã·âäœçŽã¢ã«ãã¬ã³ãäœçŽã¢ã«ãã«ã¢
ããâäœçŽã¢ã«ãã¬ã³åã¯äœçŽãžã¢ã«ãã«ã¢ãã
âäœçŽã¢ã«ãã¬ã³ããããã°ããåºãããããã
R7ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«âäœçŽã¢ã«
ãã¬ã³åã¯ããšãã«ããªâäœçŽã¢ã«ãã¬ã³ããã
ãã°ããåºããããããïœã¯ïŒåã¯ïŒã®æŽæ°ãš
ããã¯ååŠçµåãââãââããåŒãå ã¯NR9ããããããäœãR9ã¯æ°ŽçŽ ãäœçŽã¢ã«ã
ã«ãããšãã«ãåã¯ããšãã«âäœçŽã¢ã«ãã¬ã³ã
ãããããäœããååŠçµåã§ãããšãã¯ïŒºã¯ïŒ
âã€ã³ããªã«ç°ãããããããã€ïŒºã¯æ°ŽçŽ ãäœçŽ
ã¢ã«ãã«åã¯äœçŽã¢ã«ã³ãã·ããç¡é¢ä¿ã«ããã°
ããïŒä¹è³ïŒã®çœ®æåºã§çœ®æãããããšãã«ãã
ãšãã«âäœçŽã¢ã«ãã¬ã³åã¯ïŒâã€ã³ããªã«ãã
æã矀ããããã°ããåºããããããïŒã§ç€ºãã
ãååç©åã¯ãã®è£œè¬äžèš±å®¹ãããé žä»å å¡©ãæ
å¹æåãšããé«è¡å§çæ²»çå€ã ïŒïŒ åŒïŒ ïŒäžåŒäžR2ãR5ãR6ã¯åç¡é¢ä¿ã«äœçŽïŒC1â
C4ïŒã¢ã«ãã«ãããããã·äœçŽã¢ã«ãã¬ã³ãäœ
çŽã¢ã«ã³ãã·âäœçŽã¢ã«ãã¬ã³ãäœçŽã¢ã«ãã«ã¢
ããâäœçŽã¢ã«ãã¬ã³åã¯äœçŽãžã¢ã«ãã«ã¢ãã
âäœçŽã¢ã«ãã¬ã³ããããã°ããåºãããããã
R7ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«âäœçŽã¢ã«
ãã¬ã³åã¯ããšãã«ããªâäœçŽã¢ã«ãã¬ã³ããã
ãã°ããåºããããããïœã¯ïŒåã¯ïŒã®æŽæ°ãš
ããã¯ååŠçµåãââãââããåŒãå ã¯NR9ããããããäœãR9ã¯æ°ŽçŽ ãäœçŽã¢ã«ã
ã«ãããšãã«ãåã¯ããšãã«âäœçŽã¢ã«ãã¬ã³ã
ãããããäœããååŠçµåã§ãããšãã¯ïŒºã¯ïŒ
âã€ã³ããªã«ç°ãããããããã€ïŒºã¯æ°ŽçŽ ãäœçŽ
ã¢ã«ãã«åã¯äœçŽã¢ã«ã³ãã·ããç¡é¢ä¿ã«ããã°
ããïŒä¹è³ïŒã®çœ®æåºã§çœ®æãããããšãã«ãã
ãšãã«âäœçŽã¢ã«ãã¬ã³åã¯ïŒâã€ã³ããªã«ãã
æã矀ããããã°ããåºããããããïŒã§ç€ºãã
ãååç©åã¯ãã®è£œè¬äžèš±å®¹ãããé žä»å å¡©ãæ
å¹æåãšããèè¡çæ²»çå€ã ïŒïŒ åŒïŒ ïŒäžåŒäžR2ãR5ãR6ã¯åç¡é¢ä¿ã«äœçŽïŒC1â
C4ïŒã¢ã«ãã«ãããããã·äœçŽã¢ã«ãã¬ã³ãäœ
çŽã¢ã«ã³ãã·âäœçŽã¢ã«ãã¬ã³ãäœçŽã¢ã«ãã«ã¢
ããâäœçŽã¢ã«ãã¬ã³åã¯äœçŽãžã¢ã«ãã«ã¢ãã
âäœçŽã¢ã«ãã¬ã³ããããã°ããåºãããããã
R7ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«âäœçŽã¢ã«
ãã¬ã³åã¯ããšãã«ããªâäœçŽã¢ã«ãã¬ã³ããã
ãã°ããåºããããããïœã¯ïŒåã¯ïŒã®æŽæ°ãš
ããã¯ååŠçµåãââãââããåŒãå ã¯NR9ããããããäœãR9ã¯æ°ŽçŽ ãäœçŽã¢ã«ã
ã«ãããšãã«ãåã¯ããšãã«âäœçŽã¢ã«ãã¬ã³ã
ãããããäœããååŠçµåã§ãããšãã¯ïŒºã¯ïŒ
âã€ã³ããªã«ç°ãããããããã€ïŒºã¯æ°ŽçŽ ãäœçŽ
ã¢ã«ãã«åã¯äœçŽã¢ã«ã³ãã·ããç¡é¢ä¿ã«ããã°
ããïŒä¹è³ïŒã®çœ®æåºã§çœ®æãããããšãã«ãã
ãšãã«âäœçŽã¢ã«ãã¬ã³åã¯ïŒâã€ã³ããªã«ãã
æã矀ããããã°ããåºããããããïŒã§ç€ºãã
ãååç©åã¯ãã®è£œè¬äžèš±å®¹ãããé žä»å å¡©ãæ
å¹æåãšããè¡å°æ¿æ©èœæå¶æ²»çå€ã ïŒïŒ åŒïŒ ïŒäžåŒäžR2ãR5ãR6ã¯åç¡é¢ä¿ã«äœçŽïŒC1â
C4ïŒã¢ã«ãã«ãããããã·äœçŽã¢ã«ãã¬ã³ãäœ
çŽã¢ã«ã³ãã·âäœçŽã¢ã«ãã¬ã³ãäœçŽã¢ã«ãã«ã¢
ããâäœçŽã¢ã«ãã¬ã³åã¯äœçŽãžã¢ã«ãã«ã¢ãã
âäœçŽã¢ã«ãã¬ã³ããããã°ããåºãããããã
R7ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«âäœçŽã¢ã«
ãã¬ã³åã¯ããšãã«ããªâäœçŽã¢ã«ãã¬ã³ããã
ãã°ããåºããããããïœã¯ïŒåã¯ïŒã®æŽæ°ãš
ããã¯ååŠçµåãââãââããåŒãå ã¯NR9ããããããäœãR9ã¯æ°ŽçŽ ãäœçŽã¢ã«ã
ã«ãããšãã«ãåã¯ããšãã«âäœçŽã¢ã«ãã¬ã³ã
ãããããäœããååŠçµåã§ãããšãã¯ïŒºã¯ïŒ
âã€ã³ããªã«ç°ãããããããã€ïŒºã¯æ°ŽçŽ ãäœçŽ
ã¢ã«ãã«åã¯äœçŽã¢ã«ã³ãã·ããç¡é¢ä¿ã«ããã°
ããïŒä¹è³ïŒã®çœ®æåºã§çœ®æãããããšãã«ãã
ãšãã«âäœçŽã¢ã«ãã¬ã³åã¯ïŒâã€ã³ããªã«ãã
æã矀ããããã°ããåºããããããïŒã§ç€ºãã
ãååç©åã¯ãã®è£œè¬äžèš±å®¹ãããé žä»å å¡©ïŒä¹
è³50mgãšè£œè¬äžèš±å®¹ãããç¡æ¯äžæŽ»æ§æ äœããæ
ãé«è¡å§çåã¯èè¡é¢é£çãããããå¿èè¡ç®¡ç
æ²»çå€ã ïŒïŒ åŒïŒ äœãR2ãR5ãR6ã¯ç¬ç«ã«äœçŽïŒC1-4ïŒã¢ã«ã
ã«ãããããã·âäœçŽã¢ã«ãã¬ã³ãäœçŽã¢ã«ã³ã
ã·âäœçŽã¢ã«ãã¬ã³ãäœçŽã¢ã«ãã«ã¢ããâäœçŽ
ã¢ã«ãã¬ã³åã¯äœçŽãžã¢ã«ãã«ã¢ããâäœçŽã¢ã«
ãã¬ã³ããéžã°ãïŒ ïŒ¹ã¯ããã²ã³ãNHR7åã¯ïŒ®ïŒR7ïŒïŒCH2ïŒnXZ
ã§ããïŒR7ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«â
äœçŽã¢ã«ãã¬ã³åã¯ããšãã«ããªâäœçŽã¢ã«ãã¬
ã³ããéžã°ãïŒ ïœã¯ïŒåã¯ïŒã§ããïŒ ïŒžã¯ååŠçµåãââãââããåŒãå㯠âNR9âã§ãããR9ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãã
ãšãã«åã¯ããšãã«âäœçŽã¢ã«ãã¬ã³ã§ãããã
ãååŠçµåã§ãããšãã¯ïŒºã¯ïŒâã€ã³ããªã«ç°
ã§ããïŒãã㊠ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«åã¯äœçŽã¢ã«ã³ãã·ã®
äžããç¬ç«ã«éžã°ããïŒãïŒçœ®æåºããã€ããšã
ã«ãããšãã«âäœçŽã¢ã«ãã¬ã³ãåã¯ïŒâã€ã³ã
ãªã«ããéžã°ããïŒ ã§ç€ºãããååç©ã補é ãïŒ ïŒ¹ãããã²ã³ã§ããåŒã®ååç©ãåŒ äœãR7ãïœãåã³ïŒºã¯åèšå®çŸ©ã®ãšããã§
ããïŒã§ç€ºãããååç©ãšåå¿ããïŒ ïŒ¹ãNHR7ã§ããåŒã®ååç©ãåŒ ïŒ¬âïŒCH2ïŒïœâXZ ïŒïŒ äœãã¯è±é¢ããåºã§ãããïœãåã³ïŒºã¯å
èšå®çŸ©ã®ãšããã§ããïŒã§ç€ºãããååç©ãšåå¿
ããïŒ ïŒ¹ãïŒR7ïŒïŒCH2ïŒnXZã§ïŒžãç¡«é»ã§ããåŒ
ã®ååç©ãé žåããŠåŸèšåŒã®å¯Ÿå¿ã¹ã«ããã·
ãã«ãããïŒåã¯ åŒ äœãR5ãšR6ã¯åèšå®çŸ©ã®ãšããã§ããïŒã§ç€º
ãããååç©ãåŒ äœãR2ã¯åèšå®çŸ©ã®ãšããã§ãããã¯ïŒ®
ïŒR7ïŒâïŒCH2ïŒnXZã§ããïŒã§ç€ºãããååç©ãš
åå¿ããïŒãããŠææã«ããåŸèšåŒã®ååç©ã
補è¬äžèš±å®¹ãããé žä»å å¡©ã«å€æããããšãç¹åŸŽ
ãšããåŒ ã§ç€ºãããååç©åã¯è£œè¬äžèš±å®¹ãããé žä»å å¡©
ã®è£œé æ³ã
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/852,856 US4814455A (en) | 1986-04-16 | 1986-04-16 | Dihydro-3,5-dicarboxylates |
| US852856 | 1997-05-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62281860A JPS62281860A (ja) | 1987-12-07 |
| JPH0515704B2 true JPH0515704B2 (ja) | 1993-03-02 |
Family
ID=25314403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62092129A Granted JPS62281860A (ja) | 1986-04-16 | 1987-04-16 | ã¢ã«ãã¬ã³ã¢ããã¢ã«ãã¬ã³ããããåååºãæãããžãããâïŒïŒïŒâãžã«ã«ããã·ã¬âã |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4814455A (ja) |
| EP (1) | EP0247345A3 (ja) |
| JP (1) | JPS62281860A (ja) |
| CA (1) | CA1320205C (ja) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT394043B (de) * | 1985-08-21 | 1992-01-27 | Glaxo Spa | Verfahren zur herstellung von neuen dihydropyridinderivaten |
| US5602174A (en) * | 1986-02-15 | 1997-02-11 | Beecham Wuefling Gmbh & Co. | Treatment |
| GB8603765D0 (en) * | 1986-02-15 | 1986-03-19 | Beecham Wuelfung Gmbh & Co Kg | Compounds |
| JPS63112560A (ja) * | 1986-10-29 | 1988-05-17 | Green Cross Corp:The | ãžãããããªãžã³èªå°äœ |
| DE4131346A1 (de) * | 1991-09-20 | 1993-03-25 | Bayer Ag | Indolsulfonamid substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| DE4222770A1 (de) * | 1992-07-10 | 1994-01-13 | Bayer Ag | Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine |
| JP4734924B2 (ja) * | 2004-01-13 | 2011-07-27 | äžè±çŠæ¯ååŠæ ªåŒäŒç€Ÿ | ç°ç¶ã«ã«ããã³é žãšã¹ãã«ã®è£œé æ¹æ³ |
| EP3408266B1 (en) * | 2016-01-26 | 2020-11-18 | AtatÃŒrk Ãniversitesi Bilimsel Arastirma Projeleri Birimi | N3,n6-bis(2-(5-methoxy-1h-indole-3-yl)ethyl)-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxamide and use thereof in the field of neurotoxicity |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
| US3883543A (en) * | 1969-05-10 | 1975-05-13 | Bayer Ag | N-alkyl-1,4-dihydropyridines |
| CH603575A5 (ja) * | 1974-08-19 | 1978-08-31 | Hoffmann La Roche | |
| JPS5762257A (en) * | 1980-10-03 | 1982-04-15 | Yoshitomi Pharmaceut Ind Ltd | 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt |
| DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
| DE3208628A1 (de) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| WO1983003249A1 (en) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | 1,4-dihydropyridine-3,5-dicarboxylate derivatives |
| EP0094159B1 (en) * | 1982-05-10 | 1990-03-14 | Takeda Chemical Industries, Ltd. | Dihydropyridine derivatives, their production and use |
| IL68524A0 (en) * | 1982-05-21 | 1983-07-31 | Haessle Ab | Novel dihydropyridines |
| EP0097821B1 (en) * | 1982-06-03 | 1988-07-13 | Pierrel S.p.A. | Dihydropyridines with an antagonistic activity to calcium, process for their preparation, and pharmaceutical compositions containing them |
| AU561213B2 (en) * | 1983-06-02 | 1987-04-30 | Teijin Limited | 1, 4-dihydropyridine derivative |
| JPS60120861A (ja) * | 1983-12-02 | 1985-06-28 | Otsuka Pharmaceut Co Ltd | ãžãããããªãžã³èªå°äœ |
| JPS60136558A (ja) * | 1983-12-24 | 1985-07-20 | Teikoku Hormone Mfg Co Ltd | ïŒïŒïŒâãžãããããªãžã³èªå°äœ |
| JPS60156671A (ja) * | 1984-01-25 | 1985-08-16 | Yamanouchi Pharmaceut Co Ltd | ãžãããããªãžã³èªå°äœããã³ãã®è£œé æ³ |
| IL77843A (en) * | 1985-02-11 | 1989-07-31 | Syntex Inc | Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them |
-
1986
- 1986-04-16 US US06/852,856 patent/US4814455A/en not_active Expired - Fee Related
-
1987
- 1987-04-15 EP EP87105601A patent/EP0247345A3/en not_active Ceased
- 1987-04-15 CA CA000534742A patent/CA1320205C/en not_active Expired - Fee Related
- 1987-04-16 JP JP62092129A patent/JPS62281860A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| CA1320205C (en) | 1993-07-13 |
| EP0247345A3 (en) | 1987-12-23 |
| JPS62281860A (ja) | 1987-12-07 |
| US4814455A (en) | 1989-03-21 |
| EP0247345A2 (en) | 1987-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880002357B1 (ko) | ëíëë¡íŒëŠ¬ë ì ë첎ì ì ì¡°ë°©ë² | |
| DE3787346T2 (de) | Dihydropyridin-Derivate, ihre Herstellung und ihre Verwendung. | |
| EP0176956B1 (de) | Neue Diarylverbindungen | |
| JPS626703B2 (ja) | ||
| JPH0517908B2 (ja) | ||
| KR920005742B1 (ko) | ìœì íì ì ì©í ëíìŽëë¡íŒëŠ¬ëëë칎륎복ì€ë ìŽíž ìë§ìŽë ë° ìì€í 륎ì ì ì¡°ë°©ë² | |
| HU213405B (en) | Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compns. comprising the said compds. | |
| FI91634B (fi) | MenetelmÀ terapeuttisesti kÀyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| JPH0515704B2 (ja) | ||
| US4895846A (en) | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moieties | |
| EP0257616B1 (en) | Dihydropyridine derivates and pharmaceutical composition thereof | |
| JP3053418B2 (ja) | æ°èŠã®çœ®æã¢ã«ãã«ãããªãžã³ãšã³ã¬ã¹ãããŒã«åæé»å®³å€ãšããŠã®ãã®çšé | |
| FI60705C (fi) | Foerfarande foer framstaellning av 1,4-dihydro-2,6-dimetyl-4-(3-nitrofenyl)-3,5-pyridinkarboxylsyraisopropyl-(2-propoxi-etyl)-ester som anvaendes som perifer vasodilatator | |
| HUT52055A (en) | Process for producing basic 4-aryl-dihydropyridin-amides and pharmaceutical compositions containing them | |
| US4886819A (en) | Dihydropyridine derivatives and pharmaceutical composition thereof | |
| JP2640245B2 (ja) | ïŒïŒïŒâãžãããããªãžã³èªå°äœ | |
| JPH0723349B2 (ja) | ïŒïŒïŒâãžâã¿âã·ã€ãªâããã«âïŒâããããã·ã±ã€ç®é žã¢ããèªå°äœ | |
| EP0220917B1 (en) | 1,4-dihydropyridine pharmaceutical derivatives and their salts, and the preparation thereof | |
| EP0242829A1 (de) | Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| JPH0527624B2 (ja) | ||
| JPH0155268B2 (ja) | ||
| JPS6134424B2 (ja) | ||
| KR800000411B1 (ko) | íŽë졞늰 ì ë첎ì ì ì¡°ë°©ë² | |
| å€æéåž et al. | Novel 2-Amino-1, 4-dihydropyridine Calcium Antagonists. II. Synthesis and Antihypertensive Effects of 2-Amino-1, 4-dihydropyridine Derivatives Having N, N-Dialkylaminoalkoxycarbonyl Groups at 3-and/or 5-Position. | |
| JPH0526778B2 (ja) |